Exact Mass: 312.1725354

Exact Mass Matches: 312.1725354

Found 500 metabolites which its exact mass value is equals to given mass value 312.1725354, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Yakuchinone-A

3-Heptanone, 1-(4-hydroxy-3-methoxyphenyl)-7-phenyl-

C20H24O3 (312.1725354)


1-(4-hydroxy-3-methoxyphenyl)-7-phenyl-3-heptanone is a ketone that is heptan-3-one substituted by a 4-hydroxy-3-methoxyphenyl group at position 1 and a phenyl group at position 7. Isolated from in Alpinia oxyphylla, it exhibits antineoplastic and inhibitory activities against COX-1, COX-2 and NO synthase. It has a role as a metabolite, a cyclooxygenase 1 inhibitor, a cyclooxygenase 2 inhibitor, an EC 1.14.13.39 (nitric oxide synthase) inhibitor and an antineoplastic agent. It is a monomethoxybenzene, a member of phenols and a ketone. Yakuchinone-A is a natural product found in Alpinia oxyphylla with data available. Yakuchinone A is a natural product isolated from the fruit of Alpinia oxyphylla, which can induce apoptosis and has anticancer and anti-inflammatory activities[1]. Yakuchinone A is a natural product isolated from the fruit of Alpinia oxyphylla, which can induce apoptosis and has anticancer and anti-inflammatory activities[1].

   

Benzyl butyl phthalate

Butyl phenylmethyl 1,2-benzenedicarboxylic acid

C19H20O4 (312.13615200000004)


CONFIDENCE standard compound; INTERNAL_ID 837; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10079; ORIGINAL_PRECURSOR_SCAN_NO 10074 CONFIDENCE standard compound; INTERNAL_ID 837; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10050; ORIGINAL_PRECURSOR_SCAN_NO 10045 CONFIDENCE standard compound; INTERNAL_ID 837; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10050; ORIGINAL_PRECURSOR_SCAN_NO 10048 CONFIDENCE standard compound; INTERNAL_ID 837; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10020; ORIGINAL_PRECURSOR_SCAN_NO 10018 CONFIDENCE standard compound; INTERNAL_ID 837; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10069; ORIGINAL_PRECURSOR_SCAN_NO 10066 CONFIDENCE standard compound; INTERNAL_ID 837; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9995; ORIGINAL_PRECURSOR_SCAN_NO 9990 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3597 CONFIDENCE standard compound; INTERNAL_ID 8369 D009676 - Noxae > D013723 - Teratogens

   

Oseltamivir

Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid

C16H28N2O4 (312.20489680000003)


Oseltamivir is only found in individuals that have used or taken this drug. It is an acetamido cyclohexene that is a structural homolog of sialic acid and inhibits neuraminidase. [PubChem]Oseltamivir is an ethyl ester prodrug requiring ester hydrolysis for conversion to the active form, oseltamivir carboxylate. The proposed mechanism of action of oseltamivir is inhibition of influenza virus neuraminidase with the possibility of alteration of virus particle aggregation and release. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AH - Neuraminidase inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 658 CONFIDENCE standard compound; INTERNAL_ID 2068 D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Granisetron

1-Methyl-N-(endo-9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide

C18H24N4O (312.19500139999997)


Granisetron is only found in individuals that have used or taken this drug. It is a serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic and antinauseant for cancer chemotherapy patients. [PubChem]Granisetron is a potent, selective antagonist of 5-HT3 receptors. The antiemetic activity of the drug is brought about through the inhibition of 5-HT3 receptors present both centrally (medullary chemoreceptor zone) and peripherally (GI tract). This inhibition of 5-HT3 receptors in turn inhibits the visceral afferent stimulation of the vomiting center, likely indirectly at the level of the area postrema, as well as through direct inhibition of serotonin activity within the area postrema and the chemoreceptor trigger zone. A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants > A04AA - Serotonin (5ht3) antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Granisetron (BRL 43694) is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy.

   

Praziquantel

2-cyclohexanecarbonyl-1H,2H,3H,4H,6H,7H,11bH-piperazino[2,1-a]isoquinolin-4-one

C19H24N2O2 (312.18376839999996)


Praziquantel is only found in individuals that have used or taken this drug. It is an anthelmintic used in most schistosome and many cestode infestations. [PubChem]Praziquantel works by causing severe spasms and paralysis of the worms muscles. This paralysis is accompanied - and probably caused - by a rapid Ca 2+ influx inside the schistosome. Morphological alterations are another early effect of praziquantel. These morphological alterations are accompanied by an increased exposure of schistosome antigens at the parasite surface. The worms are then either completely destroyed in the intestine or passed in the stool. An interesting quirk of praziquantel is that it is relatively ineffective against juvenile schistosomes. While initially effective, effectiveness against schistosomes decreases until it reaches a minimum at 3-4 weeks. Effectiveness then increases again until it is once again fully effective at 6-7 weeks. Glutathione S-transferase (GST), an essential detoxification enzyme in parasitic helminths, is a major vaccine target and a drug target against schistosomiasis. Schistosome calcium ion channels are currently the only known target of praziquantel. P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02B - Antitrematodals > P02BA - Quinoline derivatives and related substances D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

   

Olanzapine

5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),3(7),5,8,10,12-hexaene

C17H20N4S (312.14086000000003)


Olanzapine was the third atypical antipsychotic to gain approval by the Food and Drug Administration (FDA) and has become one of the most commonly used atypical antipsychotics. Olanzapine has been approved by the FDA for the treatment of schizophrenia, acute mania in bipolar disorder, agitation associated with schizophrenia and bipolar disorder, and as maintenance treatment in bipolar disorder and psychotic depression. It has also been established in treating depression off-label because of its mood-stabilizing properties and its ability to increase the efficacy of antidepressants. Olanzapine is manufactured and marketed by the pharmaceutical company Eli Lilly and Company. It is available as a pill that comes in the strengths of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg and as as Zydis orally disintegrating tablets in the strengths of 5 mg, 10 mg, 15 mg, and 20 mg. It is also available as a rapid-acting intramuscular injection for short term acute use. Olanzapine (oh-LAN-za-peen, sold as Zyprexa, Zydis, or in combination with fluoxetine, as Symbyax) was the third atypical antipsychotic to gain approval by the Food and Drug Administration (FDA) and has become one of the most commonly used atypical antipsychotics. Olanzapine has been approved by the FDA for the treatment of schizophrenia, acute mania in bipolar disorder, agitation associated with schizophrenia and bipolar disorder, and as maintenance treatment in bipolar disorder and psychotic depression. Olanzapine was the third atypical antipsychotic to gain approval by the Food and Drug Administration (FDA) and has become one of the most commonly used atypical antipsychotics. Olanzapine has been approved by the FDA for the treatment of schizophrenia, acute mania in bipolar disorder, agitation associated with schizophrenia and bipolar disorder, and as maintenance treatment in bipolar disorder and psychotic depression. N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AH - Diazepines, oxazepines, thiazepines and oxepines D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics CONFIDENCE standard compound; INTERNAL_ID 1517 D049990 - Membrane Transport Modulators Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptor (Ki=19 nM). Olanzapine is an atypical antipsychotic[1][2].

   
   
   

Broussonin C

5-[3-[4-Hydroxy-3-(3-methylbut-2-enyl)phenyl]propyl]benzene-1,3-diol

C20H24O3 (312.1725354)


   

2',3,4',5-Tetrahydroxy-4-prenylstilbene

5-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-2-(3-methylbut-2-en-1-yl)benzene-1,3-diol

C19H20O4 (312.13615200000004)


2,3,4,5-Tetrahydroxy-4-prenylstilbene is found in fruits. 2,3,4,5-Tetrahydroxy-4-prenylstilbene is a constituent of Artocarpus incisus (breadfruit) and Morus alba (white mulberry) Constituent of Artocarpus incisus (breadfruit) and Morus alba (white mulberry). 2,3,4,5-Tetrahydroxy-4-prenylstilbene is found in fruits.

   

Centrolobine

d-Centrolobine

C20H24O3 (312.1725354)


   

norajmaline

norajmaline

C19H24N2O2 (312.18376839999996)


An organonitrogen heterocyclic compound that is ajmaline which is lacking the methyl substituent attached to the nitrogen of the dihydroindole moiety.

   

(±)-2,4,6-Triphenyl-1-hexene

(3,5-diphenylhex-5-en-1-yl)benzene

C24H24 (312.1877904)


Styrene trimer. Present as an impurity in polystyrene food containers and other products - liberated on heating. Styrene trimer. Present as an impurity in polystyrene food containers and other products - liberated on heating

   

m-(beta-Acetyl-alpha-ethyl-p-hydroxyphenethyl)benzoic acid

m-(beta-Acetyl-alpha-ethyl-p-hydroxyphenethyl)benzoic acid

C19H20O4 (312.13615200000004)


   

1,3,5-Triphenylcyclohexane

2(5)-Phenyl-2(1),2(2),2(3),2(4),2(5),2(6)-hexahydro-1(1),2(1):2(3),3(1)-terphenyl

C24H24 (312.1877904)


1,3,5-Triphenylcyclohexane is a packaging migration residue. Present as an impurity in polystyrene food containers and other products; liberated on heating. Packaging migration residue. Present as an impurity in polystyrene food containers and other products; liberated on heating

   

AR-42

N-[4-[(hydroxyamino)carbonyl]phenyl]-αS-(1-methylethyl)-benzeneacetamide

C18H20N2O3 (312.147385)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

1,3-Dipropyl-8-phenylxanthine

1,3-Dipropyl-8-phenylxanthine

C17H20N4O2 (312.158618)


   

Phenylalanylphenylalanine

(2S)-2-{[(2S)-2-azaniumyl-3-phenylpropanoyl]amino}-3-phenylpropanoate

C18H20N2O3 (312.147385)


Phenylalanylphenylalanine (Phe-Phe) is a peptide made of two phenylalanine molecules. Phenylalanine is an essential amino acid and the precursor for the amino acid tyrosine. Like tyrosine, it is the precursor of catecholamines in the body (tyramine, dopamine, epinephrine and norepinephrine). The psychotropic drugs (mescaline, morphine, codeine, and papaverine) also have phenylalanine as a constituent. Phenylalanine is a precursor of the neurotransmitters called catecholamines, which are adrenalin-like substances. Phenylalanine is highly concentrated in the human brain and plasma. The Phe-Phe recognition motif of the Alzheimer?s Abeta peptide is the smallest peptide able to assemble into higher ?order structures.(PMC:1796831) [HMDB] Phenylalanylphenylalanine (Phe-Phe) is a peptide made of two phenylalanine molecules. Phenylalanine is an essential amino acid and the precursor for the amino acid tyrosine. Like tyrosine, it is the precursor of catecholamines in the body (tyramine, dopamine, epinephrine and norepinephrine). The psychotropic drugs (mescaline, morphine, codeine, and papaverine) also have phenylalanine as a constituent. Phenylalanine is a precursor of the neurotransmitters called catecholamines, which are adrenalin-like substances. Phenylalanine is highly concentrated in the human brain and plasma. The Phe-Phe recognition motif of Alzheimers amyloid-beta peptide is the smallest peptide able to assemble into higher-order structures (PMID: 17172307).

   

Methyl (9Z)-10'-oxo-6,10'-diapo-6-carotenoate

Methyl (4Z,6E,8E,10E,12E,14E)-4,8,13-trimethyl-16-oxohexadeca-2,4,6,8,10,12,14-heptaenoic acid

C20H24O3 (312.1725354)


Methyl (9Z)-10-oxo-6,10-diapo-6-carotenoate is a constituent of Bixa orellana (annatto) Constituent of Bixa orellana (annatto).

   

5-Methoxy-7-(4-hydroxyphenyl)-1-phenyl-3-heptanone

7-(4-hydroxyphenyl)-5-methoxy-1-phenylheptan-3-one

C20H24O3 (312.1725354)


5-Methoxy-7-(4-hydroxyphenyl)-1-phenyl-3-heptanone is found in herbs and spices. 5-Methoxy-7-(4-hydroxyphenyl)-1-phenyl-3-heptanone is a constituent of Alpinia officinarum (lesser galangal). Constituent of Alpinia officinarum (lesser galangal). 5-Methoxy-7-(4-hydroxyphenyl)-1-phenyl-3-heptanone is found in herbs and spices.

   

Tetrahydrobisdemethoxydiferuloylmethane

Tetrahydrobisdemethoxydiferuloylmethane

C19H20O4 (312.13615200000004)


   

4-(3-Methyl-1-butenyl)-3,3',4',5-tetrahydroxystilbene

5-[(Z)-2-(3,4-dihydroxyphenyl)ethenyl]-2-[(1E)-3-methylbut-1-en-1-yl]benzene-1,3-diol

C19H20O4 (312.13615200000004)


(E,E)-Arachidin I is found in nuts. (E,E)-Arachidin I is a constituent of peanuts (Arachis hypogaea). Constituent of peanuts (Arachis hypogaea). (E,E)-Arachidin I is found in nuts.

   

Chloropanaxydiol

1-chloro-8-(3-heptyloxiran-2-yl)octa-4,6-diyne-2,3-diol

C17H25ClO3 (312.14921300000003)


Chloropanaxydiol is found in tea. Chloropanaxydiol is isolated from the dried callus of Panax ginseng (ginseng

   
   

(1E)-5-hydroxy-1,7-bis(4-hydroxyphenyl)hept-1-en-3-one

(1E)-5-hydroxy-1,7-bis(4-hydroxyphenyl)hept-1-en-3-one

C19H20O4 (312.13615200000004)


   

4'-Hydroxy-5,5'-diisopropyl-2,2'-dimethyl-3,4-biphenylquinone

4-[4-hydroxy-2-methyl-5-(propan-2-yl)phenyl]-3-methyl-6-(propan-2-yl)cyclohexa-3,5-diene-1,2-dione

C20H24O3 (312.1725354)


4-Hydroxy-5,5-diisopropyl-2,2-dimethyl-3,4-biphenylquinone is found in herbs and spices. 4-Hydroxy-5,5-diisopropyl-2,2-dimethyl-3,4-biphenylquinone is a constituent of the leaves of thyme (Thymus vulgaris). Shows antioxidant activity. Constituent of the leaves of thyme (Thymus vulgaris). Shows antioxidant activity. 4-Hydroxy-5,5-diisopropyl-2,2-dimethyl-3,4-biphenylquinone is found in herbs and spices.

   

Gancaonin V

8-(3-methylbut-2-en-1-yl)-9,10-dihydrophenanthrene-2,3,5,7-tetrol

C19H20O4 (312.13615200000004)


Gancaonin V is found in herbs and spices. Gancaonin V is a constituent of Glycyrrhiza uralensis (Chinese licorice). Constituent of Glycyrrhiza uralensis (Chinese licorice). Gancaonin V is found in herbs and spices.

   

Honyudisin

5-Hydroxy-8,8-dimethyl-6-(3-methyl-2-butenyl)-2H,8H-benzo[1,2-b:3,4-b]dipyran-2-one, 9ci

C19H20O4 (312.13615200000004)


Honyudisin is found in citrus. Honyudisin is a constituent of Citrus grandis (pummelo). Constituent of Citrus grandis (pummelo). Honyudisin is found in citrus.

   

Ethopropazine

N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine

C19H24N2S (312.1660104)


Ethopropazine is only found in individuals that have used or taken this drug.Ethopropazine (also known as profenamine hydrochloride) is a medication derived from phenothiazine. It is primarily used as an antidyskinetic to treat parkinsonism. It is sold under the trade names Parsidol in the United States and Parsidan in Canada.Ethopropazines antiparkinson action can be attributed to its anticholinergic properties. Ethopropazine partially blocks central (striatal) cholinergic receptors, thereby helping to balance cholinergic and dopaminergic activity in the basal ganglia; salivation may be decreased, and smooth muscle may be relaxed. Drug-induced extrapyramidal symptoms and those due to parkinsonism may be relieved, but tardive dyskinesia is not alleviated and may be aggravated by anticholinergic effects. Ethopropazines local anesthetic effect is due to its antagonism of the NMDA glutamate receptor. Glutamate is recognized as an important transmitter in nociceptive pathways, and the N-methyl-D-aspartate (NMDA) subtype of the glutamate receptor, in particular, has been implicated in the mediation of neuropathic pain. Excessive release of glutamate at NMDA receptors on dorsal horn neurons of the spinal cord results in hyperactivation and hypersensitivity of these receptors (perceived as hyperalgesia), thought to be an integral feature of neuropathic pain. N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

   

N-Undecylbenzenesulfonic acid

4-Undecylbenzene-1-sulphonic acid

C17H28O3S (312.1759058)


N-Undecylbenzenesulfonic acid is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") It is used as a food additive .

   

1,2,3,4-Tetrahydro-1-phenyl-4-(2-phenylethyl)naphthalene

1-phenyl-4-(2-phenylethyl)-1,2,3,4-tetrahydronaphthalene

C24H24 (312.1877904)


1,2,3,4-Tetrahydro-1-phenyl-4-(2-phenylethyl)naphthalene is a packaging migration residue. Packaging migration residue

   

1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene

1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene

C24H24 (312.1877904)


1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene is a packaging migration residue. Packaging migration residue

   

2-hydroxyethinylestradiol

(17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-2,3,17-triol

C20H24O3 (312.1725354)


2-hydroxyethinylestradiol is a metabolite of ethinyl estradiol. Ethinyl estradiol (EE) /ˌɛθɨnɨlˌiːstrəˈdaɪ.əl/, also sometimes written as ethinylestradiol, ethynyl estradiol, or ethinyl œstradiol, is a derivative of 17β-estradiol (E2), the major endogenous estrogen in humans. EE is an orally bioactive estrogen used in many formulations of combined oral contraceptive pills. It is one of the most commonly used medications for this purpose. (Wikipedia)

   

Arteether

10-ethoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0⁴,¹³.0⁸,¹³]hexadecane

C17H28O5 (312.1936638)


   

6,7-Dimethyl-2,3-di-2-pyridylquinoxaline

6,7-dimethyl-2,3-bis(pyridin-2-yl)quinoxaline

C20H16N4 (312.1374896)


   

(S)-N-Hydroxy-4-(3-methyl-2-phenylbutanamido)benzamide

N-hydroxy-4-[(3-methyl-2-phenylbutanoyl)amino]benzamide

C18H20N2O3 (312.147385)


   

Chlorin

21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21)-decaene

C20H16N4 (312.1374896)


   

Propamidine

4-[3-(4-carbamimidoylphenoxy)propoxy]benzene-1-carboximidamide

C17H20N4O2 (312.158618)


D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AC - Biguanides and amidines D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives

   

1-Isopropyl-6-methylergoline-8-carboxylic acid

6-methyl-11-(propan-2-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene-4-carboxylic acid

C19H24N2O2 (312.18376839999996)


   

2-(1-Phenylpentoxycarbonyl)benzoic acid

2-{[(1-phenylpentyl)oxy]carbonyl}benzoic acid

C19H20O4 (312.13615200000004)


   

Xylamidine

N-[2-(3-methoxyphenoxy)propyl]-2-(3-methylphenyl)ethanimidamide

C19H24N2O2 (312.18376839999996)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   

21,22,23,24-Tetrahydroporphyrin

21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3,5,7,9,11,13,15,17,19-decaene

C20H16N4 (312.1374896)


   

Ethyl 4-methyl-5-(1-methylethoxy)-9H-pyrido(3,4-b)indole-3-carboxylate

Ethyl 4-methyl-5-(propan-2-yloxy)-9H-pyrido[3,4-b]indole-3-carboxylic acid

C18H20N2O3 (312.147385)


D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

Nordentatin

5-hydroxy-2,2-dimethyl-6-(2-methylbut-3-en-2-yl)-2H,8H-pyrano[2,3-h]chromen-8-one

C19H20O4 (312.13615200000004)


Nordentatin is a member of the class of compounds known as angular pyranocoumarins. Angular pyranocoumarins are organic compounds containing a pyran (or a hydrogenated derivative) angularly fused to a coumarin moiety. Nordentatin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Nordentatin can be found in sweet orange, which makes nordentatin a potential biomarker for the consumption of this food product.

   

Norajmaline

13-Ethyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol

C19H24N2O2 (312.1837684)


Norajmaline is a member of the class of compounds known as ajmaline-sarpagine alkaloids. Ajmaline-sarpagine alkaloids are organic compounds containing either of the ajmalan, sarpagan skeleton, or derivative thereof. The Sarpagine (Akuammidine) group, based on the sarpagan nucleus, arises from bond formation between C-16 and C-5 of the corynantheine precursor. Ajmaline alkaloids are based on a 17,19-secoyohimban skeleton (oxayohimban) which is invariably present as an ether. Norajmaline is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Norajmaline can be found in a number of food items such as roselle, chayote, savoy cabbage, and onion-family vegetables, which makes norajmaline a potential biomarker for the consumption of these food products.

   

Eriosematin

5-Hydroxy-8,8-dimethyl-10-(3-methylbut-2-en-1-yl)pyrano[3,2-g]chromen-4(8H)-one

C19H20O4 (312.13615200000004)


Eriosematin is a natural product found in Eriosema tuberosum with data available.

   

Hypolide

Phenanthro(1,2-c)furan-1(3H)-one, 3b,4,5,9b,10,11-hexahydro-6-hydroxy-9b-methyl-7-(1-methylethyl)-, (3bR-trans)-

C20H24O3 (312.1725354)


(3bR,9bS)-6-hydroxy-9b-methyl-7-propan-2-yl-3,3b,4,5,10,11-hexahydronaphtho[2,1-e]isobenzofuran-1-one is an oxo steroid. Triptophenolide is a natural product found in Tripterygium regelii, Tripterygium hypoglaucum, and other organisms with data available. Triptophenolide is a colorless crystalline plate isolated from ethyl acetate extracts of Tripterygium wilfordii. IC50 value: Target: In vitro: Triptophenolide can remarkably inhibit the delayed type hypersensitivity (DTH) reaction induced by DNCB and BSA; and diminished the peripheral blood ANAE+lymphocytes in rats and micc. Moreover, triptophenolide can dramatically increase the amount of total serum complement and significautly decrcase the serum antibody products (1gG ) of rats and mice. The phagocytosis of perioneal exudate macrophages in mice present double effects in vitro [1]. In vivo: Triptophenolide is a colorless crystalline plate isolated from ethyl acetate extracts of Tripterygium wilfordii. IC50 value: Target: In vitro: Triptophenolide can remarkably inhibit the delayed type hypersensitivity (DTH) reaction induced by DNCB and BSA; and diminished the peripheral blood ANAE+lymphocytes in rats and micc. Moreover, triptophenolide can dramatically increase the amount of total serum complement and significautly decrcase the serum antibody products (1gG ) of rats and mice. The phagocytosis of perioneal exudate macrophages in mice present double effects in vitro [1]. In vivo:

   

Thymol glucoside

Thymol-beta-D-glucoside

C16H24O6 (312.1572804)


   

6-hydroxy-9b-methyl-7-propan-2-yl-3,3b,4,5,10,11-hexahydronaphtho[2,1-e][2]benzofuran-1-one

6-hydroxy-9b-methyl-7-propan-2-yl-3,3b,4,5,10,11-hexahydronaphtho[2,1-e][2]benzofuran-1-one

C20H24O3 (312.1725354)


   

(+)-Neomethynolide

(+)-Neomethynolide

C17H28O5 (312.1936638)


   
   
   
   
   
   
   

2-EpicycloisoBrachycoumarin

2-EpicycloisoBrachycoumarin

C20H24O3 (312.1725354)


   
   
   
   
   

4-Geranyloxy-5-methyl coumarin

4-Geranyloxy-5-methyl coumarin

C20H24O3 (312.1725354)


   
   
   

Hydrocupreine

6-Hydroxydihydrocinchonidine

C19H24N2O2 (312.18376839999996)


   
   
   

2alpha-Hydroxyjatropholone

(+)-2alpha-Hydroxyjatropholone

C20H24O3 (312.1725354)


   

3-Oxomicrostegiol

3-Oxomicrostegiol

C20H24O3 (312.1725354)


   
   
   

Stapfinine

5-hydroxyvoaphylline

C19H24N2O2 (312.18376839999996)


   
   
   
   
   
   
   
   

Cyclobrachycoumarin

Cyclobrachycoumarin

C20H24O3 (312.1725354)


   

Rubifolide

(+)-Rubifolide

C20H24O3 (312.1725354)


   
   
   
   
   
   
   

Stemofuran O

Stemofuran O

C19H20O4 (312.13615200000004)


A natural product found in Stemona aphylla.

   

2beta-Hydroxyjatropholone

(+)-2beta-Hydroxyjatropholone

C20H24O3 (312.1725354)


   

Desmosdumotin C

2- [ (1E,2E) -1-Hydroxy-3-phenyl-2-propenylidene ] -4,6,6-trimethyl-5-methoxy-4-cyclohexene-1,3-dione

C19H20O4 (312.13615200000004)


   

2-(2-Ethoxyphenyl)-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one

2-(2-Ethoxyphenyl)-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one

C17H20N4O2 (312.158618)


   

5-(2-Ethoxyphenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one

5-(2-Ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]-7-pyrimidinone

C17H20N4O2 (312.158618)


   
   

Ethanediamide, N-(2-ethoxyphenyl)-N-(2-ethylphenyl)-

Ethanediamide, N-(2-ethoxyphenyl)-N-(2-ethylphenyl)-

C18H20N2O3 (312.147385)


   

olanzapine

Olanzapine (Zyprexa)

C17H20N4S (312.14086000000003)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AH - Diazepines, oxazepines, thiazepines and oxepines D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D049990 - Membrane Transport Modulators CONFIDENCE standard compound; INTERNAL_ID 1517 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3697 Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptor (Ki=19 nM). Olanzapine is an atypical antipsychotic[1][2].

   

4-(undecan-5-yl)benzene-1-sulfonic acid

4-(undecan-5-yl)benzene-1-sulfonic acid

C17H28O3S (312.1759058)


   
   
   

THYMOL-B-D-GLUCOPYRANOSIDE

THYMOL-B-D-GLUCOPYRANOSIDE

C16H24O6 (312.1572804)


   

nor-Dentatin

nor-Dentatin

C19H20O4 (312.13615200000004)


A natural product found in Clausena harmandiana.

   

1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)hept-4-en-3-one

1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)hept-4-en-3-one

C19H20O4 (312.13615200000004)


   

Pyrenophorol

5,13-Dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

C16H24O6 (312.1572804)


   

7,12-dihydroxy-1,5(10),6,8,12-abietapentaene-11,14-dione|sanigerone

7,12-dihydroxy-1,5(10),6,8,12-abietapentaene-11,14-dione|sanigerone

C19H20O4 (312.13615200000004)


   
   

tetrahydropyrenophorin

tetrahydropyrenophorin

C16H24O6 (312.1572804)


   

17alpha-ethynylestra-1,3,5(10)-trien-3,6alpha,17beta-triol|19-norpregna-1,3,5(10)-triene-20-yne-3,6alpha,17beta-triol|6alpha-hydroxy-ethinylestradiol|6alpha-hydroxy-ethynylestradiol

17alpha-ethynylestra-1,3,5(10)-trien-3,6alpha,17beta-triol|19-norpregna-1,3,5(10)-triene-20-yne-3,6alpha,17beta-triol|6alpha-hydroxy-ethinylestradiol|6alpha-hydroxy-ethynylestradiol

C20H24O3 (312.1725354)


   
   

2-Phenyl-4--6-hydroxymethyl-2,3-dihydro-1,4-benzoxazin-3-on|6-hydroxymethyl-4-(2-methylamino-ethyl)-2-phenyl-4H-benzo[1,4]oxazin-3-one

2-Phenyl-4--6-hydroxymethyl-2,3-dihydro-1,4-benzoxazin-3-on|6-hydroxymethyl-4-(2-methylamino-ethyl)-2-phenyl-4H-benzo[1,4]oxazin-3-one

C18H20N2O3 (312.147385)


   
   
   
   
   
   
   
   

2,6-dimethyl-8-[(2-oxo-2h-1-benzopyran-7-yl)oxy]-2,6-octadienal

2,6-dimethyl-8-[(2-oxo-2h-1-benzopyran-7-yl)oxy]-2,6-octadienal

C19H20O4 (312.13615200000004)


   
   
   
   

3,4,18beta-cyclopropa-14-oxo-ent-abieta-8,9,13,15-dien-16,12-olide|retusolide B

3,4,18beta-cyclopropa-14-oxo-ent-abieta-8,9,13,15-dien-16,12-olide|retusolide B

C20H24O3 (312.1725354)


   
   

9E-Isomer-Neolaugerine|neolaugerine

9E-Isomer-Neolaugerine|neolaugerine

C19H24N2O2 (312.18376839999996)


   

Peroxyplakoric acid A3

Peroxyplakoric acid A3

C17H28O5 (312.1936638)


   

methyl (Z)-4-<(2E,5E)-3,7-dimethylocta-2,5,7-trienyloxy>cinnamate

methyl (Z)-4-<(2E,5E)-3,7-dimethylocta-2,5,7-trienyloxy>cinnamate

C20H24O3 (312.1725354)


   

N(1)-desacetyl 18-hydroxyisoretuline|N-desacetyl-18-hydroxyisoretuline|Na-Desacetyl-18-hydroxyisoretuline

N(1)-desacetyl 18-hydroxyisoretuline|N-desacetyl-18-hydroxyisoretuline|Na-Desacetyl-18-hydroxyisoretuline

C19H24N2O2 (312.18376839999996)


   

15,16-Epoxy-neo-clerodan-1,3,13(16),14-tetraen-18,19-olide

15,16-Epoxy-neo-clerodan-1,3,13(16),14-tetraen-18,19-olide

C20H24O3 (312.1725354)


   

(3S,5R)-3-Hydroxy-5-methoxy-1-(4-hydroxyphenyl)-7-phenyl-6E-heptene

(3S,5R)-3-Hydroxy-5-methoxy-1-(4-hydroxyphenyl)-7-phenyl-6E-heptene

C20H24O3 (312.1725354)


   
   
   
   

(4bS,8aS)-4b,5,6,7,8,8a-Hexahydro-3-hydroxy-4b,8,8-trimethyl-2-(2-propenyl)phenanthren-1,4-dion|Lanugon A

(4bS,8aS)-4b,5,6,7,8,8a-Hexahydro-3-hydroxy-4b,8,8-trimethyl-2-(2-propenyl)phenanthren-1,4-dion|Lanugon A

C20H24O3 (312.1725354)


   

cleistha-8,11,13-trien-7-one-19,20beta-olide

cleistha-8,11,13-trien-7-one-19,20beta-olide

C20H24O3 (312.1725354)


   
   
   

Botrydial, dihydro-

Botrydial, dihydro-

C17H28O5 (312.1936638)


   

<5-(2-Methoxy-4-vinylphenyl)-3-furylmethyl>angelat|Angeloyl-4-Hydroxymethyl-2-(2-methoxy-5-vinylphenyl)-furan|[5-(2-Methoxy-4-vinylphenyl)-3-furylmethyl]angelat

<5-(2-Methoxy-4-vinylphenyl)-3-furylmethyl>angelat|Angeloyl-4-Hydroxymethyl-2-(2-methoxy-5-vinylphenyl)-furan|[5-(2-Methoxy-4-vinylphenyl)-3-furylmethyl]angelat

C19H20O4 (312.13615200000004)


   
   
   

7-oxo-18(4->3)abeo-abieta-3,8,11,13-tetraen-18-oic acid

7-oxo-18(4->3)abeo-abieta-3,8,11,13-tetraen-18-oic acid

C20H24O3 (312.1725354)


   
   
   

2-(4-hydroxy-phenyl)-6-methyl-4-(2-methylamino-ethyl)-4H-benzo[1,4]oxazin-3-one|2-<4(?)-Hydroxyphenyl>-4--6-methyl-2,3-dihydro-1,4-benzoxazin-3-on

2-(4-hydroxy-phenyl)-6-methyl-4-(2-methylamino-ethyl)-4H-benzo[1,4]oxazin-3-one|2-<4(?)-Hydroxyphenyl>-4--6-methyl-2,3-dihydro-1,4-benzoxazin-3-on

C18H20N2O3 (312.147385)


   
   

Gravelliferon-methylaether|gravelliferone methyl ether|Me ether-Gravelliferone|Methyl-gravelliferon

Gravelliferon-methylaether|gravelliferone methyl ether|Me ether-Gravelliferone|Methyl-gravelliferon

C20H24O3 (312.1725354)


   
   
   
   

4beta-acetoxy-9beta,10beta,15alpha-trihydroxyprobotrydial

4beta-acetoxy-9beta,10beta,15alpha-trihydroxyprobotrydial

C17H28O5 (312.1936638)


   

(1S*,6R*,7S*,8S*,11R*)-6,11-diphenyltricyclo[6.2.2.02,7]dodeca-2,9-diene

(1S*,6R*,7S*,8S*,11R*)-6,11-diphenyltricyclo[6.2.2.02,7]dodeca-2,9-diene

C24H24 (312.1877904)


   

2-carboxyl-4-(3-methyl-but-2-enyl)-5-methoxy-(1,1-biphenyl)-3-ol

2-carboxyl-4-(3-methyl-but-2-enyl)-5-methoxy-(1,1-biphenyl)-3-ol

C19H20O4 (312.13615200000004)


   

17alpha-ethynyl-1,4-estradien-10,17beta-diol-3-one|17alpha-Ethynyl-1,4-estradiene-10,17beta-diol-3-one

17alpha-ethynyl-1,4-estradien-10,17beta-diol-3-one|17alpha-Ethynyl-1,4-estradiene-10,17beta-diol-3-one

C20H24O3 (312.1725354)


   
   
   

(3aS,5aR,12bS,12cR)-2,3,3a,4,5a,6,11,12,12b,12c-decahydro-3a,12b-dimethylfuro[3,2:5,6]cyclohepta[1,2:3,4]naphtho[1,8-bc]furan-9(1H)-one|limbatenolide B

(3aS,5aR,12bS,12cR)-2,3,3a,4,5a,6,11,12,12b,12c-decahydro-3a,12b-dimethylfuro[3,2:5,6]cyclohepta[1,2:3,4]naphtho[1,8-bc]furan-9(1H)-one|limbatenolide B

C20H24O3 (312.1725354)


   
   

Me ether-Ostruthin

Me ether-Ostruthin

C20H24O3 (312.1725354)


   
   
   
   

4-Methyl-2-(2,3-dimethylbenzyl)-3-[[(3-methyl-2-butenoyl)oxy]methyl]furan

4-Methyl-2-(2,3-dimethylbenzyl)-3-[[(3-methyl-2-butenoyl)oxy]methyl]furan

C20H24O3 (312.1725354)


   

11,12E-dehydrostrictic acid

11,12E-dehydrostrictic acid

C20H24O3 (312.1725354)


   

1,2,11,12E-tetradehydrohardwickiic acid

1,2,11,12E-tetradehydrohardwickiic acid

C20H24O3 (312.1725354)


   
   

(3S,6S)-3-acetoxy-2,2,6-trimethyl-6-([1S,4R]-4-hydroperoxy-4-methylcyclohex-2-en-1-yl)tetrahydropyran

(3S,6S)-3-acetoxy-2,2,6-trimethyl-6-([1S,4R]-4-hydroperoxy-4-methylcyclohex-2-en-1-yl)tetrahydropyran

C17H28O5 (312.1936638)


   
   

17-Hydroxy-16-decarbomethoxydihydroepiajmalicine

17-Hydroxy-16-decarbomethoxydihydroepiajmalicine

C19H24N2O2 (312.18376839999996)


   
   
   

E-1-[2,4-dihydroxy-5-(3-hydroxy-3-methylbutyl)benzyl]-2-phenylethylene|erythbidin C

E-1-[2,4-dihydroxy-5-(3-hydroxy-3-methylbutyl)benzyl]-2-phenylethylene|erythbidin C

C20H24O3 (312.1725354)


   

11-hydroxy-5,7,9,13-abietatetraene-2,12-dione

11-hydroxy-5,7,9,13-abietatetraene-2,12-dione

C20H24O3 (312.1725354)


   

3-oxoandrost-4,6,15-trien-16-oic acid

3-oxoandrost-4,6,15-trien-16-oic acid

C20H24O3 (312.1725354)


   

Cneorum-Chromon-H

Cneorum-Chromon-H

C20H24O3 (312.1725354)


   
   
   

2-methyl-5-(1-methylethyl)phenyl beta-D-glucopyranoside|2-methyl-5-(1-methylethyl)phenyl-beta-D-glucopyranoside|carvacryl beta-D-glucopyranoside

2-methyl-5-(1-methylethyl)phenyl beta-D-glucopyranoside|2-methyl-5-(1-methylethyl)phenyl-beta-D-glucopyranoside|carvacryl beta-D-glucopyranoside

C16H24O6 (312.1572804)


   
   

3-Ethyl-3-hydroxy-1,3-ethano-1,3-propanospiro[1H-indole-2(3H),2-piperidine]-9-one

3-Ethyl-3-hydroxy-1,3-ethano-1,3-propanospiro[1H-indole-2(3H),2-piperidine]-9-one

C19H24N2O2 (312.18376839999996)


   
   
   
   

4-epi-curcusone E

4-epi-curcusone E

C20H24O3 (312.1725354)


   
   
   

12-Hydroxysapriparaquinone

12-Hydroxysapriparaquinone

C20H24O3 (312.1725354)


   

2,3,4-trimethylbenzyl alcohol-O-beta-D-glucopyranoside|2,3,4-trimethylbenzylalcohol-O-beta-D-glucopyranoside

2,3,4-trimethylbenzyl alcohol-O-beta-D-glucopyranoside|2,3,4-trimethylbenzylalcohol-O-beta-D-glucopyranoside

C16H24O6 (312.1572804)


   

Pygmaeocin C|Pygmaoecin C

Pygmaeocin C|Pygmaoecin C

C20H24O3 (312.1725354)


   

2-Hydroxysaprorthoquinone

2-Hydroxysaprorthoquinone

C20H24O3 (312.1725354)


   

1-acetate of lapiferol

1-acetate of lapiferol

C17H28O5 (312.1936638)


   

10-Chloro-1-heptadecene-4,6-diyne-3,8,9-triol

10-Chloro-1-heptadecene-4,6-diyne-3,8,9-triol

C17H25ClO3 (312.14921300000003)


   

(R)-p-cymen-9-yl beta-glucopyranoside

(R)-p-cymen-9-yl beta-glucopyranoside

C16H24O6 (312.1572804)


   
   

(12R)-4-methoxy-2-oxatricyclo[13.2.2.13,7]icosa-3,5,7(20),15,17,18-hexaen-12-ol|2-O-methyl acerogenin A|acerogenin 2-methyl ether|acerogenin A methyl ether

(12R)-4-methoxy-2-oxatricyclo[13.2.2.13,7]icosa-3,5,7(20),15,17,18-hexaen-12-ol|2-O-methyl acerogenin A|acerogenin 2-methyl ether|acerogenin A methyl ether

C20H24O3 (312.1725354)


   

3-(1,1-dimethylallyl)-8-(3,3-dimethylallyl)-7-methoxycoumarin

3-(1,1-dimethylallyl)-8-(3,3-dimethylallyl)-7-methoxycoumarin

C20H24O3 (312.1725354)


   

(3aS,5aR,12bS,12cR)-2,3,3a,4,5a,6,11,12,12b,12c-decahydro-3a,12b-dimethylfuro[3,2:5,6]cyclohepta[1,2:3,4]naphtho[1,8-bc]furan-7(1H)-one|limbatenolide A

(3aS,5aR,12bS,12cR)-2,3,3a,4,5a,6,11,12,12b,12c-decahydro-3a,12b-dimethylfuro[3,2:5,6]cyclohepta[1,2:3,4]naphtho[1,8-bc]furan-7(1H)-one|limbatenolide A

C20H24O3 (312.1725354)


   

(ent-12E)-15,16-Epoxy-1,3,12,13(16),14-clerodapentaen-18-oic acid

(ent-12E)-15,16-Epoxy-1,3,12,13(16),14-clerodapentaen-18-oic acid

C20H24O3 (312.1725354)


   

(2S,3R,4S,4aR,7S,7aS,3R,5R,Z)-2-(3,5-dimethylhept-1-enyl)-3,4-dihydroxy-7-methyl-4,4a,7,7a-tetrahydro-2H-furo[3,4-b]pyran-5(3H)-one|fusidilactone E

(2S,3R,4S,4aR,7S,7aS,3R,5R,Z)-2-(3,5-dimethylhept-1-enyl)-3,4-dihydroxy-7-methyl-4,4a,7,7a-tetrahydro-2H-furo[3,4-b]pyran-5(3H)-one|fusidilactone E

C17H28O5 (312.1936638)


   

(5R,7S,10S)-7alpha,16,7beta,20-diepoxycleistantha-8,11,13-trien-3-one|(5S,7S,10R)-7alpha,16-7beta,20-Diepoxycleistantha-8,11,13-trien-3-one|<5S,7S,10R>-7alpha,16: 7beta,20-diepoxycleistantha-8,11,13-triene-3-one

(5R,7S,10S)-7alpha,16,7beta,20-diepoxycleistantha-8,11,13-trien-3-one|(5S,7S,10R)-7alpha,16-7beta,20-Diepoxycleistantha-8,11,13-trien-3-one|<5S,7S,10R>-7alpha,16: 7beta,20-diepoxycleistantha-8,11,13-triene-3-one

C20H24O3 (312.1725354)


   

3-Ethyl-2,20-dioxabicyclo(14.3.1(eicosa-3,6,9,16,19-pentaen-12-yn-18-one

3-Ethyl-2,20-dioxabicyclo(14.3.1(eicosa-3,6,9,16,19-pentaen-12-yn-18-one

C20H24O3 (312.1725354)


   

4-O-Me 鈥樎?S)-Acerogenin A

4-O-Me 鈥樎?S)-Acerogenin A

C20H24O3 (312.1725354)


   

Me ester-(+_)-2,5-Dihydro-2-methoxy-3,4-dimethyl-5-oxo-2-furannonanoic acid

Me ester-(+_)-2,5-Dihydro-2-methoxy-3,4-dimethyl-5-oxo-2-furannonanoic acid

C17H28O5 (312.1936638)


   

3alpha-Acetoxy-7-hydroxy-5beta-isobutyryloxy-carvotanacetone

3alpha-Acetoxy-7-hydroxy-5beta-isobutyryloxy-carvotanacetone

C16H24O6 (312.1572804)


   

6-deoxo-5,6-didehydrolanugon Q

6-deoxo-5,6-didehydrolanugon Q

C20H24O3 (312.1725354)


   

7-O-methylkoninginin D

7-O-methylkoninginin D

C17H28O5 (312.1936638)


   

4,6-decadiyne-1-O-beta-D-glucopyranoside|carthamoside A2

4,6-decadiyne-1-O-beta-D-glucopyranoside|carthamoside A2

C16H24O6 (312.1572804)


   

1-(13-hydroxy-2,4,8-tetradecatrienoyl)glycerol

1-(13-hydroxy-2,4,8-tetradecatrienoyl)glycerol

C17H28O5 (312.1936638)


   
   

7a,8,10,11-tetrahydro-3,8,8,11a-tetramethyl-phenanthro(10,1bc)pyran5(4H),9(7H)-dione|<5S,7S,10S>-3-oxo-cleistantha-8,11,13-trien-(16 - 7beta)-olide|[5S,7S,10S]-3-oxo-cleistantha-8,11,13-trien-(16 - 7beta)-olide

7a,8,10,11-tetrahydro-3,8,8,11a-tetramethyl-phenanthro(10,1bc)pyran5(4H),9(7H)-dione|<5S,7S,10S>-3-oxo-cleistantha-8,11,13-trien-(16 - 7beta)-olide|[5S,7S,10S]-3-oxo-cleistantha-8,11,13-trien-(16 - 7beta)-olide

C20H24O3 (312.1725354)


   

de-O-ethylsalvonitin

de-O-ethylsalvonitin

C20H24O3 (312.1725354)


   

3,4,18beta-cyclopropa-14-oxo-ent-abieta-7,13,15-dien-16,12-olide|retusolide C

3,4,18beta-cyclopropa-14-oxo-ent-abieta-7,13,15-dien-16,12-olide|retusolide C

C20H24O3 (312.1725354)


   

(E)-methyl 3-[2,2-dimethyl-8-(3-methylbut-2-en-1-yl)-2H-chromen-6-yl]acrylate|8-(3,3-dimethylallyl)wenteria chromene|8-<3,3-dimethylallyl>-werneria chromene

(E)-methyl 3-[2,2-dimethyl-8-(3-methylbut-2-en-1-yl)-2H-chromen-6-yl]acrylate|8-(3,3-dimethylallyl)wenteria chromene|8-<3,3-dimethylallyl>-werneria chromene

C20H24O3 (312.1725354)


   
   

4-Carbomethoxyathrixianon|4-Methoxycarbonylathrixianone

4-Carbomethoxyathrixianon|4-Methoxycarbonylathrixianone

C20H24O3 (312.1725354)


   
   

1-Oxo-salvibretol

1-Oxo-salvibretol

C20H24O3 (312.1725354)


   
   

Macaline A

1H-Imidazolium, 4,5-dimethyl-1,3-bis(phenylmethyl)-, chloride (1:1)

C19H21ClN2 (312.1393176)


See also: Lepidium meyenii root (part of). Lepidiline A shows cytotoxic activity against HL-60 cells with an IC50 of 32.3 μM.

   

Artemotil

(1R,4S,5R,8S,9R,10S,12R,13R)-10-ethoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecane

C17H28O5 (312.1936638)


Artemotil is an artemisinin derivative. Artemotil, also known as β-arteether, is a semi-synthetic derivative of artemisinin and a fast acting blood schizonticide specifically indicated for the treatment of chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria cases. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BE - Artemisinin and derivatives, plain D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides Artemotil (β-Arteether) has antimalarial activity for the treatment of chloroquine-resistant Plasmodium falciparum malaria with an IC50 of 1.61 nM. Artemotil also has central nervous system (CNS) neurotoxicity and anorectic toxicity in rats, dogs and monkeys[1][2]. Artemotil (β-Arteether) has antimalarial activity for the treatment of chloroquine-resistant Plasmodium falciparum malaria with an IC50 of 1.61 nM. Artemotil also has central nervous system (CNS) neurotoxicity and anorectic toxicity in rats, dogs and monkeys[1][2].

   

1-Oxomicrostegiol

1-Oxomicrostegiol

C20H24O3 (312.1725354)


   
   

praziquantel

Praziquantel (Biltricide)

C19H24N2O2 (312.18376839999996)


P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02B - Antitrematodals > P02BA - Quinoline derivatives and related substances D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent CONFIDENCE standard compound; INTERNAL_ID 164; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8927; ORIGINAL_PRECURSOR_SCAN_NO 8925 CONFIDENCE standard compound; INTERNAL_ID 164; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8934; ORIGINAL_PRECURSOR_SCAN_NO 8932 CONFIDENCE standard compound; INTERNAL_ID 164; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8954; ORIGINAL_PRECURSOR_SCAN_NO 8953 CONFIDENCE standard compound; INTERNAL_ID 164; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8977; ORIGINAL_PRECURSOR_SCAN_NO 8976 CONFIDENCE standard compound; INTERNAL_ID 164; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8993; ORIGINAL_PRECURSOR_SCAN_NO 8991 CONFIDENCE standard compound; INTERNAL_ID 2202 [Raw Data] CB144_Praziquantel_pos_50eV_CB000054.txt [Raw Data] CB144_Praziquantel_pos_40eV_CB000054.txt [Raw Data] CB144_Praziquantel_pos_30eV_CB000054.txt [Raw Data] CB144_Praziquantel_pos_20eV_CB000054.txt [Raw Data] CB144_Praziquantel_pos_10eV_CB000054.txt CONFIDENCE standard compound; EAWAG_UCHEM_ID 3272

   

Oseltamivir

Oseltamivir

C16H28N2O4 (312.20489680000003)


A cyclohexenecarboxylate ester that is the ethyl ester of oseltamivir acid. An antiviral prodrug (it is hydrolysed to the active free carboxylic acid in the liver), it is used to slow the spread of influenza. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AH - Neuraminidase inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong.

   

(3E,5S,8R,11E,13S,16R)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

NCGC00380335-01!(3E,5S,8R,11E,13S,16R)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

C16H24O6 (312.1572804)


   

C11-LAS (STANDARD MIX)

C11-LAS (STANDARD MIX)

C17H28O3S (312.1759058)


Auto-extracted from standard mix; CONFIDENCE Tentative identification: isomers possible (Level 3)

   

C11-LAS (SAMPLE)

C11-LAS (SAMPLE)

C17H28O3S (312.1759058)


Auto-extracted from 130925_neg_10.mzML; CONFIDENCE Tentative identification: isomers possible (Level 3)

   

C16H24O6_beta-D-Glucopyranoside, 5-methyl-2-(1-methylethyl)phenyl

NCGC00380175-01_C16H24O6_beta-D-Glucopyranoside, 5-methyl-2-(1-methylethyl)phenyl

C16H24O6 (312.1572804)


   

granisetron

granisetron

C18H24N4O (312.19500139999997)


A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants > A04AA - Serotonin (5ht3) antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Granisetron (BRL 43694) is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy.

   
   

Thymol-beta-D-glucoside

Thymol-beta-D-glucoside

C16H24O6 (312.1572804)


   

Triptophenolide

Phenanthro(1,2-c)furan-1(3H)-one, 3b,4,5,9b,10,11-hexahydro-6-hydroxy-9b-methyl-7-(1-methylethyl)-, (3bR-trans)-

C20H24O3 (312.1725354)


Triptophenolide is a colorless crystalline plate isolated from ethyl acetate extracts of Tripterygium wilfordii. IC50 value: Target: In vitro: Triptophenolide can remarkably inhibit the delayed type hypersensitivity (DTH) reaction induced by DNCB and BSA; and diminished the peripheral blood ANAE+lymphocytes in rats and micc. Moreover, triptophenolide can dramatically increase the amount of total serum complement and significautly decrcase the serum antibody products (1gG ) of rats and mice. The phagocytosis of perioneal exudate macrophages in mice present double effects in vitro [1]. In vivo: Triptophenolide is a colorless crystalline plate isolated from ethyl acetate extracts of Tripterygium wilfordii. IC50 value: Target: In vitro: Triptophenolide can remarkably inhibit the delayed type hypersensitivity (DTH) reaction induced by DNCB and BSA; and diminished the peripheral blood ANAE+lymphocytes in rats and micc. Moreover, triptophenolide can dramatically increase the amount of total serum complement and significautly decrcase the serum antibody products (1gG ) of rats and mice. The phagocytosis of perioneal exudate macrophages in mice present double effects in vitro [1]. In vivo:

   
   
   

ethopropazine

Ethopropazine (oxide)

C19H24N2S (312.1660104)


   

3-Hydroxypsilotin

3-Hydroxypsilotin

C20H24O3 (312.1725354)


   

Phenylalanylphenylalanine; AIF; CE0; CorrDec

Phenylalanylphenylalanine; AIF; CE0; CorrDec

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; AIF; CE10; CorrDec

Phenylalanylphenylalanine; AIF; CE10; CorrDec

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; AIF; CE30; CorrDec

Phenylalanylphenylalanine; AIF; CE30; CorrDec

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; AIF; CE0; MS2Dec

Phenylalanylphenylalanine; AIF; CE0; MS2Dec

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; AIF; CE10; MS2Dec

Phenylalanylphenylalanine; AIF; CE10; MS2Dec

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; AIF; CE30; MS2Dec

Phenylalanylphenylalanine; AIF; CE30; MS2Dec

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; LC-tDDA; CE10

Phenylalanylphenylalanine; LC-tDDA; CE10

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; LC-tDDA; CE20

Phenylalanylphenylalanine; LC-tDDA; CE20

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; LC-tDDA; CE30

Phenylalanylphenylalanine; LC-tDDA; CE30

C18H20N2O3 (312.147385)


   

Phenylalanylphenylalanine; LC-tDDA; CE40

Phenylalanylphenylalanine; LC-tDDA; CE40

C18H20N2O3 (312.147385)


   
   

Triptophenolide_major

Triptophenolide_major

C20H24O3 (312.1725354)


   

Triptophenolide_91.0\\%

Triptophenolide_91.0\\%

C20H24O3 (312.1725354)


   

Thymol-beta-D-glucoside_major

Thymol-beta-D-glucoside_major

C16H24O6 (312.1572804)


   

Triptophenolide_72.0\\%

Triptophenolide_72.0\\%

C20H24O3 (312.1725354)


   

4-Hydroxyethinylestradiol

4-Hydroxyethinylestradiol

C20H24O3 (312.1725354)


   

2-hydroxyethinylestradiol

2-Hydroxy Ethynyl Estradiol

C20H24O3 (312.1725354)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

19-Norpregna-1,3,5(10)-trien-20-yne-3,6,17-triol, (6b,17a)-

19-Norpregna-1,3,5(10)-trien-20-yne-3,6,17-triol, (6b,17a)-

C20H24O3 (312.1725354)


   

17-Ethynylestriol

17a-Ethynylestriol

C20H24O3 (312.1725354)


   
   

6-Hydroxyethinylestradiol

6-Hydroxyethinylestradiol

C20H24O3 (312.1725354)


   
   

Acitretin Ro 12-7310

Acitretin Ro 12-7310

C20H24O3 (312.1725354)


   

Apo-10'-bixinal

methyl (2E,4Z,6E,8E,10E,12E,14E)-4,8,13-trimethyl-16-oxohexadeca-2,4,6,8,10,12,14-heptaenoate

C20H24O3 (312.1725354)


   

Undecylbenzenesulfonic acid

4-Undecylbenzene-1-sulfonic acid

C17H28O3S (312.1759058)


   

Chloropanaxydiol

1-chloro-8-(3-heptyloxiran-2-yl)octa-4,6-diyne-2,3-diol

C17H25ClO3 (312.14921300000003)


   

7-(4-hydroxyphenyl)-5-methoxy-1-phenylheptan-3-one

7-(4-hydroxyphenyl)-5-methoxy-1-phenylheptan-3-one

C20H24O3 (312.1725354)


   

1-Phenyl-4-(2-phenylethyl)tetralin

1-phenyl-4-(2-phenylethyl)-1,2,3,4-tetrahydronaphthalene

C24H24 (312.1877904)


   

1-Phenyl-4-(1-phenylethyl)tetralin

1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene

C24H24 (312.1877904)


   

4'-Hydroxy-5,5'-diisopropyl-2,2'-dimethyl-3,4-biphenylquinone

4-[4-hydroxy-2-methyl-5-(propan-2-yl)phenyl]-3-methyl-6-(propan-2-yl)cyclohexa-3,5-diene-1,2-dione

C20H24O3 (312.1725354)


   

Thymolglucoside

2-Isopropyl-5-methylphenyl ?-D-glucopyranoside

C16H24O6 (312.1572804)


   

FA 17:3;O3

(7Z)-14-hydroxy-10,13-dioxo-7-heptadecenoic acid;cis-14-hydroxy-10,13-dioxo-7-heptadecenoic acid;cis-14-hydroxy-10,13-dioxoheptadec-7-enoic acid

C17H28O5 (312.1936638)


   

[4-(Dibenzylamino)phenyl]acetonitrile

[4-(Dibenzylamino)phenyl]acetonitrile

C22H20N2 (312.16264)


   

tert-Butyl 4-(phenylamino)piperidine-1-carboxylate hydrochloride

tert-Butyl 4-(phenylamino)piperidine-1-carboxylate hydrochloride

C16H25ClN2O2 (312.160446)


   

1-Benzyl-4-cyano-4-phenylpiperidine HCl

1-Benzyl-4-cyano-4-phenylpiperidine HCl

C19H21ClN2 (312.1393176)


   
   

5-Triphenylmethyl-1H-tetrazole

5-Triphenylmethyl-1H-tetrazole

C20H16N4 (312.1374896)


   

2-CHLORO-1-(TETRAHYDRO-2H-PYRAN-2-YL)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-IMIDAZOLE

2-CHLORO-1-(TETRAHYDRO-2H-PYRAN-2-YL)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-IMIDAZOLE

C14H22BClN2O3 (312.1411922)


   
   

4-(3,4,5-TRIMETHOXY-PHENYL)-2,3-DIHYDRO-1H-BENZO[B][1,4]DIAZEPINE

4-(3,4,5-TRIMETHOXY-PHENYL)-2,3-DIHYDRO-1H-BENZO[B][1,4]DIAZEPINE

C18H20N2O3 (312.147385)


   

4-[(2,6-Diisopropylphenoxy)methyl]phenylboronic acid

4-[(2,6-Diisopropylphenoxy)methyl]phenylboronic acid

C19H25BO3 (312.189665)


   

2-[(2,6-Diisopropylphenoxy)methyl]phenylboronic acid

2-[(2,6-Diisopropylphenoxy)methyl]phenylboronic acid

C19H25BO3 (312.189665)


   

Benzyl 2-butylpiperazine-1-carboxylate hydrochloride

Benzyl 2-butylpiperazine-1-carboxylate hydrochloride

C16H25ClN2O2 (312.160446)


   

4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]oxyaniline

4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]oxyaniline

C17H21BN2O3 (312.1645146000001)


   

N1-(2-Ethoxyphenyl)-N2-(2-ethylphenyl)oxalamide

N1-(2-Ethoxyphenyl)-N2-(2-ethylphenyl)oxalamide

C18H20N2O3 (312.147385)


   

N,N-Dimethyl-1,1-binaphthalene-2,2-diamine

N,N-Dimethyl-1,1-binaphthalene-2,2-diamine

C22H20N2 (312.16264)


   

(R)-N,Nμ-Dimethyl-2,2μ-diamino-1,1μ-binaphthyl,(R)-N,Nμ-Dimethyl-1,1μ-binaphthalene-2,2μ-diamine

(R)-N,Nμ-Dimethyl-2,2μ-diamino-1,1μ-binaphthyl,(R)-N,Nμ-Dimethyl-1,1μ-binaphthalene-2,2μ-diamine

C22H20N2 (312.16264)


   

(S)-2-(tert-Butyldiphenylsilanyloxy)propionaldehyde

(S)-2-(tert-Butyldiphenylsilanyloxy)propionaldehyde

C19H24O2Si (312.15454839999995)


   

2-((4-Ethoxyphenyl)amino)-2-phenyl-N-propylacetamide

2-((4-Ethoxyphenyl)amino)-2-phenyl-N-propylacetamide

C19H24N2O2 (312.18376839999996)


   

(4-((2-(PIPERIDIN-1-YL)ETHYL)CARBAMOYL)PHENYL)BORONIC ACID HYDROCHLORIDE

(4-((2-(PIPERIDIN-1-YL)ETHYL)CARBAMOYL)PHENYL)BORONIC ACID HYDROCHLORIDE

C14H22BClN2O3 (312.1411922)


   

2-[ETHYL[4-[2-(4-NITROPHENYL)ETHENYL]PHENYL]AMINO]ETHANOL

2-[ETHYL[4-[2-(4-NITROPHENYL)ETHENYL]PHENYL]AMINO]ETHANOL

C18H20N2O3 (312.147385)


   

4-octylphenethyl methanesulfonate

4-octylphenethyl methanesulfonate

C17H28O3S (312.1759058)


   
   

5,6,14,15-DIBENZO-1,4-DIOXA-8,12-DIAZACYCLOPENTADECA-5,14-DIENE

5,6,14,15-DIBENZO-1,4-DIOXA-8,12-DIAZACYCLOPENTADECA-5,14-DIENE

C19H24N2O2 (312.18376839999996)


   
   

POLYIMIDAZOLINE, QUATERNIZED

POLYIMIDAZOLINE, QUATERNIZED

C14H24N4O4 (312.1797464)


   

Ethyl7-benzyl-4-hydroxy-5,6,7,8-tetrahydro-1,7-naphthyridine-3-carboxylate

Ethyl7-benzyl-4-hydroxy-5,6,7,8-tetrahydro-1,7-naphthyridine-3-carboxylate

C18H20N2O3 (312.147385)


   
   

2-(2-Ethoxyphenyl)-5-methyl-7-propyl-3H-imidazol[5,1-f][1,2,4]-triazin-4-one

2-(2-Ethoxyphenyl)-5-methyl-7-propyl-3H-imidazol[5,1-f][1,2,4]-triazin-4-one

C17H20N4O2 (312.158618)


   

3-hydroxy-2,2-dimethylpropyl 3-hydroxy-2,2-dimethylpropionate diacrylate

3-hydroxy-2,2-dimethylpropyl 3-hydroxy-2,2-dimethylpropionate diacrylate

C16H24O6 (312.1572804)


   

2-(BENZYLOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIMIDINE

2-(BENZYLOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIMIDINE

C17H21BN2O3 (312.1645146000001)


   

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-naphthoate

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-naphthoate

C18H21BO4 (312.1532816)


   
   

1-Benzyl-4-phenylpiperidine-4-carbonitrile

1-Benzyl-4-phenylpiperidine-4-carbonitrile

C19H21ClN2 (312.1393176)


   
   

4-Piperdinyl-N-oxoethylpiperdine dihydrochloride

4-Piperdinyl-N-oxoethylpiperdine dihydrochloride

C13H26Cl2N2O2 (312.1371236)


   
   

6,7-Dimethyl-2,3-di-2-pyridylquinoxaline

Quinoxaline,6,7-dimethyl-2,3-di-2-pyridinyl-

C20H16N4 (312.1374896)


   

MESO-1,2-BIS(1-NAPHTHYL)ETHYLENEDIAMINE

MESO-1,2-BIS(1-NAPHTHYL)ETHYLENEDIAMINE

C22H20N2 (312.16264)


   

(3S,6S,8AS)-METHYL 6-((TERT-BUTOXYCARBONYL)AMINO)-5-OXOOCTAHYDROINDOLIZINE-3-CARBOXYLATE

(3S,6S,8AS)-METHYL 6-((TERT-BUTOXYCARBONYL)AMINO)-5-OXOOCTAHYDROINDOLIZINE-3-CARBOXYLATE

C15H24N2O5 (312.1685134)


   

2-Methyl-2-propanyl 7-(2-methoxy-2-oxoethyl)-6-oxo-1,7-diazaspiro [4.4]nonane-1-carboxylate

2-Methyl-2-propanyl 7-(2-methoxy-2-oxoethyl)-6-oxo-1,7-diazaspiro [4.4]nonane-1-carboxylate

C15H24N2O5 (312.1685134)


   

methyl 2-(4-benzylpiperazin-1-yl)pyrimidine-5-carboxylate

methyl 2-(4-benzylpiperazin-1-yl)pyrimidine-5-carboxylate

C17H20N4O2 (312.158618)


   

Tofacitinib

Tofacitinib

C16H20N6O (312.169851)


L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors > D000075242 - Janus Kinase Inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

(2-n-benzylaminoethyl)-3-aminopropyl-trimethoxysilane,tech-90

(2-n-benzylaminoethyl)-3-aminopropyl-trimethoxysilane,tech-90

C15H28N2O3Si (312.1869098)


   

4-Dimethylaminobenzoic anhydride

4-Dimethylaminobenzoic anhydride

C18H20N2O3 (312.147385)


   

1-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]-5-oxopyrrolidine-3-carboxylic acid

1-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]-5-oxopyrrolidine-3-carboxylic acid

C15H24N2O5 (312.1685134)


   

4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE

4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE

C19H24N2O2 (312.18376839999996)


   

2-Methyl-2-propanyl 4-[(2S)-2-(methoxycarbonyl)-1-pyrrolidinyl]-1 -piperidinecarboxylate

2-Methyl-2-propanyl 4-[(2S)-2-(methoxycarbonyl)-1-pyrrolidinyl]-1 -piperidinecarboxylate

C16H28N2O4 (312.20489680000003)


   

buta-1,3-diene,N-(hydroxymethyl)prop-2-enamide,prop-2-enenitrile,styrene

buta-1,3-diene,N-(hydroxymethyl)prop-2-enamide,prop-2-enenitrile,styrene

C19H24N2O2 (312.18376839999996)


   

[1,1-Binaphthalene]-2,2-diamine, N,N-dimethyl

[1,1-Binaphthalene]-2,2-diamine, N,N-dimethyl

C22H20N2 (312.16264)


   
   

1-(TERT-BUTOXYCARBONYL)-[1,4-BIPIPERIDINE]-4-CARBOXYLIC ACID

1-(TERT-BUTOXYCARBONYL)-[1,4-BIPIPERIDINE]-4-CARBOXYLIC ACID

C16H28N2O4 (312.20489680000003)


   

Titanium, Bu alc. iso-Pr alc. complexes

Titanium, Bu alc. iso-Pr alc. complexes

C14H32O4Ti (312.1779942)


   

(3R,4S)-Tofacitinib

(3R,4S)-Tofacitinib

C16H20N6O (312.169851)


   

(3S,4S)-Tofacitinib

(3S,4S)-Tofacitinib

C16H20N6O (312.169851)


   

(3S,4R)-Tofacitinib

(3S,4R)-Tofacitinib

C16H20N6O (312.169851)


   

(8R,9S,10R,13S,14S)-10,13-Dimethylspiro[7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthrene-6,2-oxirane]-3,17(10H,14H)-dione

(8R,9S,10R,13S,14S)-10,13-Dimethylspiro[7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthrene-6,2-oxirane]-3,17(10H,14H)-dione

C20H24O3 (312.1725354)


   

benzyl (2R)-2-butylpiperazine-1-carboxylate,hydrochloride

benzyl (2R)-2-butylpiperazine-1-carboxylate,hydrochloride

C16H25ClN2O2 (312.160446)


   

Molindone hydrochloride

(±)-Molindone Hydrochloride

C16H25ClN2O2 (312.160446)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Molindone hydrochloride (EN-1733A) is a therapeutic antipsychotic, used in the treatment of schizophrenia, works by blocking the effects of dopamine in the brain, leading to diminished psychoses.

   

2,3-Dihydro-2-spiro-7-[8-imino-7,8-dihydronaphthalen-1-amine]perimidine

2,3-Dihydro-2-spiro-7-[8-imino-7,8-dihydronaphthalen-1-amine]perimidine

C20H16N4 (312.1374896)


   
   
   

Trenbolone Acetate

Trenbolone Acetate

C20H24O3 (312.1725354)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid

   

2-[p-(Dimethylamino)benzoyl]-5-(dimethylamino)benzoic acid

2-[p-(Dimethylamino)benzoyl]-5-(dimethylamino)benzoic acid

C18H20N2O3 (312.147385)


   
   

4-(PHENYLTHIO)OCTANOPHENONE

4-(PHENYLTHIO)OCTANOPHENONE

C20H24OS (312.1547774)


   

4-(4-heptoxyphenyl)benzoic acid

4-(4-heptoxyphenyl)benzoic acid

C20H24O3 (312.1725354)


   

N,N,N,N-TETRAMETHYL-N-[TRIS(DIMETHYLAMINO)PHOSPHORANYLIDENE]PHOSPHORIC TRIAMIDE

N,N,N,N-TETRAMETHYL-N-[TRIS(DIMETHYLAMINO)PHOSPHORANYLIDENE]PHOSPHORIC TRIAMIDE

C10H30N6OP2 (312.19562299999996)


   

Olanzapine Lactam Impurity

Olanzapine Lactam Impurity

C17H20N4O2 (312.158618)


   

Anastrozole Mono Acid

Anastrozole Mono Acid

C17H20N4O2 (312.158618)


   

Granisetronum

exo-Granisetron (Granisetron Impurity F)

C18H24N4O (312.19500139999997)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

4-(2,3-Difluoro-5-Methyl-phenyl)-piperazine-1-carboxylic acid tert-butyl ester

4-(2,3-Difluoro-5-Methyl-phenyl)-piperazine-1-carboxylic acid tert-butyl ester

C16H22F2N2O2 (312.1649256)


   

arteether

3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin, 10-ethoxydecahydro-3,6,9-trimethyl-

C17H28O5 (312.1936638)


   

trans-4-(Benzyloxycarbonylamino)cyclohexanemethylamine hydrochloride

trans-4-(Benzyloxycarbonylamino)cyclohexanemethylamine hydrochloride

C16H25ClN2O2 (312.160446)


   

Amides,coco, N-[3-(dimethylamino)propyl]

5-[3-(2,5-Dimethoxyphenyl)prop-1-Yn-1-Yl]-6-Ethylpyrimidine-2,4-Diamine

C17H20N4O2 (312.158618)


   

4-Chloro-4-(trans-4-propylcyclohexyl)-1,1-biphenyl

4-Chloro-4-(trans-4-propylcyclohexyl)-1,1-biphenyl

C21H25Cl (312.164468)


   

2,4-bis(dimethoxymethyl)-2,4-bis(hydroxymethyl)pentane-1,5-diol

2,4-bis(dimethoxymethyl)-2,4-bis(hydroxymethyl)pentane-1,5-diol

C13H28O8 (312.1784088)


   

N-(4-Amino-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide, HCl

N-(4-Amino-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide, HCl

C14H22BClN2O3 (312.1411922)


   

(3-((2-(PIPERIDIN-1-YL)ETHYL)CARBAMOYL)PHENYL)BORONIC ACID HYDROCHLORIDE

(3-((2-(PIPERIDIN-1-YL)ETHYL)CARBAMOYL)PHENYL)BORONIC ACID HYDROCHLORIDE

C14H22BClN2O3 (312.1411922)


   

2-ethylhexyl (4-chloro-2-methylphenoxy)acetate

2-ethylhexyl (4-chloro-2-methylphenoxy)acetate

C17H25ClO3 (312.14921300000003)


   

ethyl-4-(triethoxysilyl) benzoate

ethyl-4-(triethoxysilyl) benzoate

C15H24O5Si (312.1392934)


   

(R)-Benzyl 2-isobutylpiperazine-1-carboxylate hydrochloride

(R)-Benzyl 2-isobutylpiperazine-1-carboxylate hydrochloride

C16H25ClN2O2 (312.160446)


   

(S)-Benzyl 2-isobutylpiperazine-1-carboxylate hydrochloride

(S)-Benzyl 2-isobutylpiperazine-1-carboxylate hydrochloride

C16H25ClN2O2 (312.160446)


   

Benzoic acid, 4-methyl-, 4-(hexyloxy)phenyl ester

Benzoic acid, 4-methyl-, 4-(hexyloxy)phenyl ester

C20H24O3 (312.1725354)


   

methyl (3s,6s,8ar)-6-[(tert-butoxycarbonyl)amino]-5-oxooctahydroindolizine-3-carboxylate

methyl (3s,6s,8ar)-6-[(tert-butoxycarbonyl)amino]-5-oxooctahydroindolizine-3-carboxylate

C15H24N2O5 (312.1685134)


   

5-amino-2-nitrobenzoic acid

5-amino-2-nitrobenzoic acid

C20H24O3 (312.1725354)


   

4-(4-amino-3-methylnaphthalen-1-yl)-2-methylnaphthalen-1-amine

4-(4-amino-3-methylnaphthalen-1-yl)-2-methylnaphthalen-1-amine

C22H20N2 (312.16264)


   
   

(R)-1-N-BOC-2-BENZYLPIPERAZINE-HCl

(R)-1-N-BOC-2-BENZYLPIPERAZINE-HCl

C16H25ClN2O2 (312.160446)


   

(S)-1-N-BOC-2-BENZYL-PIPERAZINE-HCl

(S)-1-N-BOC-2-BENZYL-PIPERAZINE-HCl

C16H25ClN2O2 (312.160446)


   

benzyl (2S)-2-butylpiperazine-1-carboxylate,hydrochloride

benzyl (2S)-2-butylpiperazine-1-carboxylate,hydrochloride

C16H25ClN2O2 (312.160446)


   

(R)-Praziquantel

(R)-Praziquantel

C19H24N2O2 (312.18376839999996)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

   

2-(4-(1,1-Dimethylethyl)cyclohexyl)-3-hydroxy-1,4-naphthalenedione

2-(4-(1,1-Dimethylethyl)cyclohexyl)-3-hydroxy-1,4-naphthalenedione

C20H24O3 (312.1725354)


   
   

Etidocaine hydrochloride

Etidocaine hydrochloride

C17H29ClN2O (312.1968294)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   
   

(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(5-isopropyl-2-methylphenoxy)tetrahydro-2H-pyran-3,4,5-triol

(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(5-isopropyl-2-methylphenoxy)tetrahydro-2H-pyran-3,4,5-triol

C16H24O6 (312.1572804)


   

2-[3-(2-Hydroxyethoxy)-2,2-bis(2-hydroxyethoxymethyl)propoxy]ethanol

2-[3-(2-Hydroxyethoxy)-2,2-bis(2-hydroxyethoxymethyl)propoxy]ethanol

C13H28O8 (312.1784088)


   
   
   

5,22-Dihydroporphyrin

5,22-Dihydroporphyrin

C20H16N4 (312.1374896)


   

1-(2-Methoxyethyl)-2-[(4-methoxyphenoxy)methyl]benzimidazole

1-(2-Methoxyethyl)-2-[(4-methoxyphenoxy)methyl]benzimidazole

C18H20N2O3 (312.147385)


   

N-[2-[(3-cyano-6-ethoxy-2-quinolinyl)amino]ethyl]propanamide

N-[2-[(3-cyano-6-ethoxy-2-quinolinyl)amino]ethyl]propanamide

C17H20N4O2 (312.158618)


   

1,2-Diphenyltryptamine

1,2-Diphenyltryptamine

C22H20N2 (312.16264)


   

6,7,8,13,14,15-Hexahydro-7,14-methanobenzo[6,7]cyclodeca[1,2-b]naphthalen-17-one

6,7,8,13,14,15-Hexahydro-7,14-methanobenzo[6,7]cyclodeca[1,2-b]naphthalen-17-one

C23H20O (312.151407)


   

(2E,4E,6E,8E)-9-(4-hydroxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid

(2E,4E,6E,8E)-9-(4-hydroxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid

C20H24O3 (312.1725354)


D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

   

5,6,7,8,9,10-Hexahydro-4-hydroxy-3-(1-phenylpropyl)cycloocta[B]pyran-2-one

5,6,7,8,9,10-Hexahydro-4-hydroxy-3-(1-phenylpropyl)cycloocta[B]pyran-2-one

C20H24O3 (312.1725354)


   

Profenamine

ethopropazine

C19H24N2S (312.1660104)


N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

   

propamidine

propamidine

C17H20N4O2 (312.158618)


D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AC - Biguanides and amidines D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives

   

Yakuchinone A

3-Heptanone, 1-(4-hydroxy-3-methoxyphenyl)-7-phenyl-

C20H24O3 (312.1725354)


Yakuchinone A is a natural product isolated from the fruit of Alpinia oxyphylla, which can induce apoptosis and has anticancer and anti-inflammatory activities[1]. Yakuchinone A is a natural product isolated from the fruit of Alpinia oxyphylla, which can induce apoptosis and has anticancer and anti-inflammatory activities[1].

   

5-(4-Sulfophenyl)undecane

5-(4-Sulfophenyl)undecane

C17H28O3S (312.1759058)


   

Glucopyranoside,2-ipr-5-ME phenyl

Glucopyranoside,2-ipr-5-ME phenyl

C16H24O6 (312.1572804)


   

Thebaine(1+)

Thebaine(1+)

C19H22NO3+ (312.1599602)


The trialkylammonium ion resulting from the protonation of the amino group of thebaine.

   

4beta-Acetoxy-10beta,15alpha-dihydroxyprobotryane

4beta-Acetoxy-10beta,15alpha-dihydroxyprobotryane

C17H28O5 (312.1936638)


   

(9R,10S,12S,13S,14R,16S,18R)-13-ethyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol

(9R,10S,12S,13S,14R,16S,18R)-13-ethyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol

C19H24N2O2 (312.18376839999996)


   

(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propylidene]amino]-3-(4-hydroxyphenyl)propanal

(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propylidene]amino]-3-(4-hydroxyphenyl)propanal

C18H20N2O3 (312.147385)


   
   

22,24-Dihydro-21H,23H-porphyrin

22,24-Dihydro-21H,23H-porphyrin

C20H16N4 (312.1374896)


   

beta-D-Glucopyranoside, 5-methyl-2-(1-methylethyl)phenyl

beta-D-Glucopyranoside, 5-methyl-2-(1-methylethyl)phenyl

C16H24O6 (312.1572804)


   

N-(4-methylphenyl)-2-pyridin-4-yl-4-quinazolinamine

N-(4-methylphenyl)-2-pyridin-4-yl-4-quinazolinamine

C20H16N4 (312.1374896)


   

4-tert-butyl-N-(4-methyl-3-nitrophenyl)benzamide

4-tert-butyl-N-(4-methyl-3-nitrophenyl)benzamide

C18H20N2O3 (312.147385)


   

5-methyl-6-pyridin-4-yl-6H-benzimidazolo[1,2-c]quinazoline

5-methyl-6-pyridin-4-yl-6H-benzimidazolo[1,2-c]quinazoline

C20H16N4 (312.1374896)


   

6-methyl-6-pyridin-4-yl-12H-benzimidazolo[1,2-c]quinazoline

6-methyl-6-pyridin-4-yl-12H-benzimidazolo[1,2-c]quinazoline

C20H16N4 (312.1374896)


   

6,7-dimethoxy-N-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxamide

6,7-dimethoxy-N-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxamide

C18H20N2O3 (312.147385)


   

1-methyl-N-[(1S,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]-3-indazolecarboxamide

1-methyl-N-[(1S,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]-3-indazolecarboxamide

C18H24N4O (312.19500139999997)


   

(3,5-dimethylphenyl)[4-(3-ethyl-4H-1,2,4-triazol-4-yl)piperidino]methanone

(3,5-dimethylphenyl)[4-(3-ethyl-4H-1,2,4-triazol-4-yl)piperidino]methanone

C18H24N4O (312.19500139999997)


   

4-[2-(3-Fluorophenyl)-5-methyl-7-pyrazolo[1,5-a]pyrimidinyl]morpholine

4-[2-(3-Fluorophenyl)-5-methyl-7-pyrazolo[1,5-a]pyrimidinyl]morpholine

C17H17FN4O (312.1386324)


   

N-[4-cyano-1-(4-fluorophenyl)-1H-pyrazol-5-yl]cyclohexanecarboxamide

N-[4-cyano-1-(4-fluorophenyl)-1H-pyrazol-5-yl]cyclohexanecarboxamide

C17H17FN4O (312.1386324)


   

N-(3-methoxyphenyl)-4-[(2-methyl-1-oxopropyl)amino]benzamide

N-(3-methoxyphenyl)-4-[(2-methyl-1-oxopropyl)amino]benzamide

C18H20N2O3 (312.147385)


   

2,3-dimethoxy-N-[4-(1-piperidinyl)phenyl]aniline

2,3-dimethoxy-N-[4-(1-piperidinyl)phenyl]aniline

C19H24N2O2 (312.18376839999996)


   

(E)-3-(((quinolin-8-ylmethylene)amino)oxy)butyl cyclopropanecarboxylate

(E)-3-(((quinolin-8-ylmethylene)amino)oxy)butyl cyclopropanecarboxylate

C18H20N2O3 (312.147385)


   

2-[(3R,6aS,8R,10aS)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

2-[(3R,6aS,8R,10aS)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

C16H28N2O4 (312.20489680000003)


   

2-[(3R,6aS,8S,10aS)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

2-[(3R,6aS,8S,10aS)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

C16H28N2O4 (312.20489680000003)


   

(2S,3E)-4-[(4aR,5aS,9R,10aR,11S,11aS)-11-hydroxy-2,3,4,4a,5a,6,9,10a,11,11a-decahydropyrano[2,3:5,6]pyrano[3,2-b]oxepin-9-yl]but-3-ene-1,2-diol

(2S,3E)-4-[(4aR,5aS,9R,10aR,11S,11aS)-11-hydroxy-2,3,4,4a,5a,6,9,10a,11,11a-decahydropyrano[2,3:5,6]pyrano[3,2-b]oxepin-9-yl]but-3-ene-1,2-diol

C16H24O6 (312.1572804)


   

2-[(3S,6aR,8S,10aR)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

2-[(3S,6aR,8S,10aR)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

C16H28N2O4 (312.20489680000003)


   

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

C16H28N2O4 (312.20489680000003)


   

2-[(3S,6aS,8S,10aS)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

2-[(3S,6aS,8S,10aS)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

C16H28N2O4 (312.20489680000003)


   

2-[(3R,6aR,8R,10aR)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

2-[(3R,6aR,8R,10aR)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

C16H28N2O4 (312.20489680000003)


   

(6S,7S,8S)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8S)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H24N2O2 (312.18376839999996)


   

(6S,7S,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H24N2O2 (312.18376839999996)


   

2-[(3S,6aR,8R,10aR)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

2-[(3S,6aR,8R,10aR)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

C16H28N2O4 (312.20489680000003)


   

2-[(3S,6aS,8R,10aS)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

2-[(3S,6aS,8R,10aS)-3-hydroxy-1-methyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide

C16H28N2O4 (312.20489680000003)


   

(6R,7S,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H24N2O2 (312.18376839999996)


   

(6R,7R,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H24N2O2 (312.18376839999996)


   

(6S,7R,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H24N2O2 (312.18376839999996)


   

(6R,7R,8S)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8S)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C19H24N2O2 (312.18376839999996)


   

1-{4-[(2-Hydroxyethyl)carbamoyl]benzyl}-1-methylpiperidinium chloride

1-{4-[(2-Hydroxyethyl)carbamoyl]benzyl}-1-methylpiperidinium chloride

C16H25ClN2O2 (312.160446)


   

6-(4-Phenylpiperazino)hexanoic acid hydrochloride

6-(4-Phenylpiperazino)hexanoic acid hydrochloride

C16H25ClN2O2 (312.160446)


   

methyl 2-methyl-4-(6-methylpyridin-2-yl)-5-oxo-4,6,7,8-tetrahydro-3H-quinoline-3-carboxylate

methyl 2-methyl-4-(6-methylpyridin-2-yl)-5-oxo-4,6,7,8-tetrahydro-3H-quinoline-3-carboxylate

C18H20N2O3 (312.147385)


   

(1R,9R,10S,12R,13S,14R,17S,18R)-13-ethyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol

(1R,9R,10S,12R,13S,14R,17S,18R)-13-ethyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol

C19H24N2O2 (312.18376839999996)


   

17beta-Hydroxyestra-4,9,11-trien-3-one, acetate

17beta-Hydroxyestra-4,9,11-trien-3-one, acetate

C20H24O3 (312.1725354)


   

5-Methyl-4,4-pentamethylene-2-para-tolylpephydropyrrolo(3,4-C)pyrrole-1,3-dione

5-Methyl-4,4-pentamethylene-2-para-tolylpephydropyrrolo(3,4-C)pyrrole-1,3-dione

C19H24N2O2 (312.18376839999996)


   

3-[(2-Oxo)-2-morpholinoethylamino]-4-methyl-6-phenylpyridazine

3-[(2-Oxo)-2-morpholinoethylamino]-4-methyl-6-phenylpyridazine

C17H20N4O2 (312.158618)


   

(3S,4S)-5-Benzyloxy-3-(2-methoxyethoxymethoxy)-4-methylpentan-2-ol

(3S,4S)-5-Benzyloxy-3-(2-methoxyethoxymethoxy)-4-methylpentan-2-ol

C17H28O5 (312.1936638)


   

3-Ethoxy-6-(5-methyl-1-methylthiomethoxy-4-hexenyl)-2-cyclohexen-1-one

3-Ethoxy-6-(5-methyl-1-methylthiomethoxy-4-hexenyl)-2-cyclohexen-1-one

C17H28O3S (312.1759058)


   

Isopropyl 2-(N-((4S)-4-(1-methylethyl)-2-oxazolidinone-3-carbamoyl)amino)-4-pentenoate

Isopropyl 2-(N-((4S)-4-(1-methylethyl)-2-oxazolidinone-3-carbamoyl)amino)-4-pentenoate

C15H24N2O5 (312.1685134)


   

Yakuchinone A

3-Heptanone, 1-(4-hydroxy-3-methoxyphenyl)-7-phenyl-

C20H24O3 (312.1725354)


1-(4-hydroxy-3-methoxyphenyl)-7-phenyl-3-heptanone is a ketone that is heptan-3-one substituted by a 4-hydroxy-3-methoxyphenyl group at position 1 and a phenyl group at position 7. Isolated from in Alpinia oxyphylla, it exhibits antineoplastic and inhibitory activities against COX-1, COX-2 and NO synthase. It has a role as a metabolite, a cyclooxygenase 1 inhibitor, a cyclooxygenase 2 inhibitor, an EC 1.14.13.39 (nitric oxide synthase) inhibitor and an antineoplastic agent. It is a monomethoxybenzene, a member of phenols and a ketone. Yakuchinone-A is a natural product found in Alpinia oxyphylla with data available. A ketone that is heptan-3-one substituted by a 4-hydroxy-3-methoxyphenyl group at position 1 and a phenyl group at position 7. Isolated from in Alpinia oxyphylla, it exhibits antineoplastic and inhibitory activities against COX-1, COX-2 and NO synthase. Yakuchinone A is a natural product isolated from the fruit of Alpinia oxyphylla, which can induce apoptosis and has anticancer and anti-inflammatory activities[1]. Yakuchinone A is a natural product isolated from the fruit of Alpinia oxyphylla, which can induce apoptosis and has anticancer and anti-inflammatory activities[1].

   

4-Undecylbenzenesulfonic acid

4-Undecylbenzenesulfonic acid

C17H28O3S (312.1759058)


   

2,4,6-Triphenyl-1-hexene

1,5-diphenylhex-5-en-3-ylbenzene

C24H24 (312.1877904)


   

Ethyl 4-methyl-5-(1-methylethoxy)-9H-pyrido(3,4-b)indole-3-carboxylate

Ethyl 4-methyl-5-(1-methylethoxy)-9H-pyrido(3,4-b)indole-3-carboxylate

C18H20N2O3 (312.147385)


D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

4-Hydroxy-5,5-diisopropyl-2,2-dimethyl-3,4-biphenylquinone

4-Hydroxy-5,5-diisopropyl-2,2-dimethyl-3,4-biphenylquinone

C20H24O3 (312.1725354)


   

1-chloro-8-(3-heptyloxiran-2-yl)octa-4,6-diyne-2,3-diol

1-chloro-8-(3-heptyloxiran-2-yl)octa-4,6-diyne-2,3-diol

C17H25ClO3 (312.14921300000003)


   

5-Methoxy-7-(4-hydroxyphenyl)-1-phenyl-3-heptanone

5-Methoxy-7-(4-hydroxyphenyl)-1-phenyl-3-heptanone

C20H24O3 (312.1725354)


   

Methyl (9Z)-10-oxo-6,10-diapo-6-carotenoate

Methyl (9Z)-10-oxo-6,10-diapo-6-carotenoate

C20H24O3 (312.1725354)


   

1,3,5-Triphenylcyclohexane

1,1,1-(1,3,5-Cyclohexanetriyl)tribenzene

C24H24 (312.1877904)


   

1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene

1,2,3,4-Tetrahydro-1-phenyl-4-(1-phenylethyl)naphthalene

C24H24 (312.1877904)


   

1-phenyl-4-(2-phenylethyl)-1,2,3,4-tetrahydronaphthalene

1-phenyl-4-(2-phenylethyl)-1,2,3,4-tetrahydronaphthalene

C24H24 (312.1877904)


   

(2S)-2-{[(2S)-2-azaniumyl-3-phenylpropanoyl]amino}-3-phenylpropanoate

(2S)-2-{[(2S)-2-azaniumyl-3-phenylpropanoyl]amino}-3-phenylpropanoate

C18H20N2O3 (312.147385)


   

(7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid

(7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid

C17H28O5 (312.1936638)


A monounsaturated fatty acid that is (7Z)-heptadec-7-enoic acid which is substituted by a hydroxy group at position 14 and by oxo groups at positions 10 and 13.

   

5,13-Dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

5,13-Dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

C16H24O6 (312.1572804)


   

Phe-phe

Phe-phe

C18H20N2O3 (312.147385)


A dipeptide formed from two L-phenylalanine residues.

   

Phe-Phe zwitterion

Phe-Phe zwitterion

C18H20N2O3 (312.147385)


An L-aminoacyl-L-amino acid zwitterion resulting from transfer of a proton from the carboxy to the amino group of L-phenylalanyl-L-phenylalanine; major species at pH 7.3.

   
   
   

Hydroxyethinylestradiol

Hydroxyethinylestradiol

C20H24O3 (312.1725354)


   

RSVA405

RSVA405

C17H20N4O2 (312.158618)


RSVA405 is a potent, orally active activator of AMPK, with an EC50 of 1 μM. RSVA405 facilitates CaMKKβ-dependent activation of AMPK, inhibits mTOR, and promotes autophagy to increase Aβ degradation. RSVA405 has anti-inflammatory effects through the inhibition of STAT3 function. RSVA405 can also be used for the research of obesity[1][2][3][4].

   

methyl (2e)-3-[2,2-dimethyl-8-(3-methylbut-2-en-1-yl)chromen-6-yl]prop-2-enoate

methyl (2e)-3-[2,2-dimethyl-8-(3-methylbut-2-en-1-yl)chromen-6-yl]prop-2-enoate

C20H24O3 (312.1725354)


   

(2r)-2,3-dihydroxypropyl (2e,4e,8e,13s)-13-hydroxytetradeca-2,4,8-trienoate

(2r)-2,3-dihydroxypropyl (2e,4e,8e,13s)-13-hydroxytetradeca-2,4,8-trienoate

C17H28O5 (312.1936638)


   

2,3,11-trihydroxy-4,6,6,10-tetramethyltricyclo[5.3.1.0⁴,¹¹]undecan-8-yl acetate

2,3,11-trihydroxy-4,6,6,10-tetramethyltricyclo[5.3.1.0⁴,¹¹]undecan-8-yl acetate

C17H28O5 (312.1936638)


   

2,4b,8,8a-tetramethyl-10-oxo-6,9-dihydro-5h-phenanthren-3-yl acetate

2,4b,8,8a-tetramethyl-10-oxo-6,9-dihydro-5h-phenanthren-3-yl acetate

C20H24O3 (312.1725354)


   

n-hexyl-2-hydroxy-n-[3-(2-oxo-5h-furan-3-yl)propanoyl]ethanehydrazonic acid

n-hexyl-2-hydroxy-n-[3-(2-oxo-5h-furan-3-yl)propanoyl]ethanehydrazonic acid

C15H24N2O5 (312.1685134)


   

(3s)-3-[(2s,4r,5s)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-3-(2-hydroxyethyl)indol-2-ol

(3s)-3-[(2s,4r,5s)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-3-(2-hydroxyethyl)indol-2-ol

C19H24N2O2 (312.18376839999996)


   

(3s,6s)-6-[(1s,4r)-4-hydroperoxy-4-methylcyclohex-2-en-1-yl]-2,2,6-trimethyloxan-3-yl acetate

(3s,6s)-6-[(1s,4r)-4-hydroperoxy-4-methylcyclohex-2-en-1-yl]-2,2,6-trimethyloxan-3-yl acetate

C17H28O5 (312.1936638)


   

(2s,5s,7r,8s,17s)-2,7,14-trimethyl-16-oxapentacyclo[9.7.0.0²,⁸.0⁵,⁷.0¹³,¹⁷]octadeca-1(11),13-diene-12,15-dione

(2s,5s,7r,8s,17s)-2,7,14-trimethyl-16-oxapentacyclo[9.7.0.0²,⁸.0⁵,⁷.0¹³,¹⁷]octadeca-1(11),13-diene-12,15-dione

C20H24O3 (312.1725354)


   

(3s,5r,7s,8r)-7,8-dihydroxy-5-(2-hydroxypropan-2-yl)-11,11-dimethyl-4,10-dioxatricyclo[7.4.0.0³,⁷]tridec-1(9)-en-13-one

(3s,5r,7s,8r)-7,8-dihydroxy-5-(2-hydroxypropan-2-yl)-11,11-dimethyl-4,10-dioxatricyclo[7.4.0.0³,⁷]tridec-1(9)-en-13-one

C16H24O6 (312.1572804)


   

(10ar)-5,6-dihydroxy-7-isopropyl-1,1,10a-trimethyl-2h-phenanthren-3-one

(10ar)-5,6-dihydroxy-7-isopropyl-1,1,10a-trimethyl-2h-phenanthren-3-one

C20H24O3 (312.1725354)


   

(2r,6as,7r,10ar)-2-hydroxy-2,5-dimethyl-10-methylidene-7-(prop-1-en-2-yl)-3h,6ah,7h,8h,9h,10ah-cyclohexa[e]azulene-1,4-dione

(2r,6as,7r,10ar)-2-hydroxy-2,5-dimethyl-10-methylidene-7-(prop-1-en-2-yl)-3h,6ah,7h,8h,9h,10ah-cyclohexa[e]azulene-1,4-dione

C20H24O3 (312.1725354)


   

2-(3-ethenylpiperidin-4-yl)-1-[3-(2-hydroxyethyl)-1h-indol-2-yl]ethanone

2-(3-ethenylpiperidin-4-yl)-1-[3-(2-hydroxyethyl)-1h-indol-2-yl]ethanone

C19H24N2O2 (312.18376839999996)


   

(2r,3s)-2,3,9-trimethyl-2-(4-methylpent-3-en-1-yl)-3h-furo[3,2-c]chromen-4-one

(2r,3s)-2,3,9-trimethyl-2-(4-methylpent-3-en-1-yl)-3h-furo[3,2-c]chromen-4-one

C20H24O3 (312.1725354)


   

3-[2-(3-ethyl-1-methylpiperidin-4-ylidene)ethylidene]-7-methoxy-1h-indol-2-one

3-[2-(3-ethyl-1-methylpiperidin-4-ylidene)ethylidene]-7-methoxy-1h-indol-2-one

C19H24N2O2 (312.18376839999996)


   

(1s,2r,7s,8r,17r)-2,7,14-trimethyl-16-oxapentacyclo[9.7.0.0²,⁸.0⁵,⁷.0¹³,¹⁷]octadeca-10,13-diene-12,15-dione

(1s,2r,7s,8r,17r)-2,7,14-trimethyl-16-oxapentacyclo[9.7.0.0²,⁸.0⁵,⁷.0¹³,¹⁷]octadeca-10,13-diene-12,15-dione

C20H24O3 (312.1725354)


   

(3z)-3-{2-[(3s,4z)-3-ethyl-1-methylpiperidin-4-ylidene]ethylidene}-7-methoxyindol-2-ol

(3z)-3-{2-[(3s,4z)-3-ethyl-1-methylpiperidin-4-ylidene]ethylidene}-7-methoxyindol-2-ol

C19H24N2O2 (312.18376839999996)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(2,3,4-trimethylphenyl)methoxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(2,3,4-trimethylphenyl)methoxy]oxane-3,4,5-triol

C16H24O6 (312.1572804)


   

12-ethyl-4,11-dihydroxy-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione

12-ethyl-4,11-dihydroxy-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione

C17H28O5 (312.1936638)


   

2,7,14-trimethyl-16-oxapentacyclo[9.7.0.0²,⁸.0⁵,⁷.0¹³,¹⁷]octadeca-10,13-diene-12,15-dione

2,7,14-trimethyl-16-oxapentacyclo[9.7.0.0²,⁸.0⁵,⁷.0¹³,¹⁷]octadeca-10,13-diene-12,15-dione

C20H24O3 (312.1725354)


   

(4ar)-5-hydroxy-7-isopropyl-1,1,4a-trimethyl-2,4-dihydrophenanthrene-3,6-dione

(4ar)-5-hydroxy-7-isopropyl-1,1,4a-trimethyl-2,4-dihydrophenanthrene-3,6-dione

C20H24O3 (312.1725354)


   

(3s)-3-[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-3-(2-hydroxyethyl)indol-2-ol

(3s)-3-[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-3-(2-hydroxyethyl)indol-2-ol

C19H24N2O2 (312.18376839999996)


   

(7s)-7-[2-(furan-3-yl)ethyl]-6,7-dimethyl-3h,4h,5h,6h-cyclodeca[c]furan-1-one

(7s)-7-[2-(furan-3-yl)ethyl]-6,7-dimethyl-3h,4h,5h,6h-cyclodeca[c]furan-1-one

C20H24O3 (312.1725354)


   

(3z,5s,11e,13r)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

(3z,5s,11e,13r)-5,13-dihydroxy-8,16-dimethyl-1,9-dioxacyclohexadeca-3,11-diene-2,10-dione

C16H24O6 (312.1572804)


   

6-(4-hydroperoxy-4-methylcyclohex-2-en-1-yl)-2,2,6-trimethyloxan-3-yl acetate

6-(4-hydroperoxy-4-methylcyclohex-2-en-1-yl)-2,2,6-trimethyloxan-3-yl acetate

C17H28O5 (312.1936638)


   

15-(2-hydroxyethyl)-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-ol

15-(2-hydroxyethyl)-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-ol

C19H24N2O2 (312.18376839999996)


   

(2r,3r,6as,7r,10ar)-3-hydroxy-2,5-dimethyl-10-methylidene-7-(prop-1-en-2-yl)-2h,3h,6ah,7h,8h,9h,10ah-cyclohexa[e]azulene-1,4-dione

(2r,3r,6as,7r,10ar)-3-hydroxy-2,5-dimethyl-10-methylidene-7-(prop-1-en-2-yl)-2h,3h,6ah,7h,8h,9h,10ah-cyclohexa[e]azulene-1,4-dione

C20H24O3 (312.1725354)


   

(9e)-12-ethyl-4,11-dihydroxy-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione

(9e)-12-ethyl-4,11-dihydroxy-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione

C17H28O5 (312.1936638)


   

7-hydroxy-2-methyl-6,8-bis(3-methylbut-2-en-1-yl)chromen-4-one

7-hydroxy-2-methyl-6,8-bis(3-methylbut-2-en-1-yl)chromen-4-one

C20H24O3 (312.1725354)


   

2-(3,5-dimethylhept-1-en-1-yl)-3,4-dihydroxy-7-methyl-hexahydrofuro[3,4-b]pyran-5-one

2-(3,5-dimethylhept-1-en-1-yl)-3,4-dihydroxy-7-methyl-hexahydrofuro[3,4-b]pyran-5-one

C17H28O5 (312.1936638)


   

2-(3,4,8-trihydroxy-3,8-dimethyl-octahydroazulen-5-yl)prop-2-en-1-yl acetate

2-(3,4,8-trihydroxy-3,8-dimethyl-octahydroazulen-5-yl)prop-2-en-1-yl acetate

C17H28O5 (312.1936638)


   

2-(hydroxymethyl)-6-[2-(4-methylphenyl)propoxy]oxane-3,4,5-triol

2-(hydroxymethyl)-6-[2-(4-methylphenyl)propoxy]oxane-3,4,5-triol

C16H24O6 (312.1572804)


   

(2r,15r,16s,18r)-15-ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.0⁴,¹².0⁵,¹⁰.0¹⁶,¹⁸]icosa-4(12),5,7,9-tetraen-2-ol

(2r,15r,16s,18r)-15-ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.0⁴,¹².0⁵,¹⁰.0¹⁶,¹⁸]icosa-4(12),5,7,9-tetraen-2-ol

C19H24N2O2 (312.18376839999996)


   

7-(4-hydroxy-3-methoxyphenyl)-1-phenylheptan-3-one

7-(4-hydroxy-3-methoxyphenyl)-1-phenylheptan-3-one

C20H24O3 (312.1725354)


   

(1r,10s,11s)-6-ethyl-5,11-dimethyl-14-oxatetracyclo[9.3.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-triene-8,12-dione

(1r,10s,11s)-6-ethyl-5,11-dimethyl-14-oxatetracyclo[9.3.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-triene-8,12-dione

C20H24O3 (312.1725354)


   

7-hydroxy-7-(6-hydroxy-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-2-yl)heptanoic acid

7-hydroxy-7-(6-hydroxy-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-2-yl)heptanoic acid

C16H24O6 (312.1572804)


   

(1e,3z,6r,7r)-6-[(1e)-2-(furan-3-yl)ethenyl]-6,7-dimethyl-10-methylidenecyclodeca-1,3-diene-1-carboxylic acid

(1e,3z,6r,7r)-6-[(1e)-2-(furan-3-yl)ethenyl]-6,7-dimethyl-10-methylidenecyclodeca-1,3-diene-1-carboxylic acid

C20H24O3 (312.1725354)


   

(2r)-2-hydroxy-1-(7-hydroxy-6-isopropyl-2-methylnaphthalen-1-yl)-4-methylpent-3-en-1-one

(2r)-2-hydroxy-1-(7-hydroxy-6-isopropyl-2-methylnaphthalen-1-yl)-4-methylpent-3-en-1-one

C20H24O3 (312.1725354)


   

10-hydroxy-1,6,6,9a-tetramethyl-1h,2h,7h,8h,9h-phenanthro[1,2-b]furan-11-one

10-hydroxy-1,6,6,9a-tetramethyl-1h,2h,7h,8h,9h-phenanthro[1,2-b]furan-11-one

C20H24O3 (312.1725354)


   

(8r,13r,16r)-13-hydroxy-8,16-dimethyl-1,9-dioxacyclohexadec-11-ene-2,5,10-trione

(8r,13r,16r)-13-hydroxy-8,16-dimethyl-1,9-dioxacyclohexadec-11-ene-2,5,10-trione

C16H24O6 (312.1572804)


   

4-[(r)-[(2s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl](hydroxy)methyl]quinolin-6-ol

4-[(r)-[(2s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl](hydroxy)methyl]quinolin-6-ol

C19H24N2O2 (312.18376839999996)


   

methyl (2z)-3-(4-{[(2e,5e)-3,7-dimethylocta-2,5,7-trien-1-yl]oxy}phenyl)prop-2-enoate

methyl (2z)-3-(4-{[(2e,5e)-3,7-dimethylocta-2,5,7-trien-1-yl]oxy}phenyl)prop-2-enoate

C20H24O3 (312.1725354)


   

13-hydroxy-3-isopropyl-1,8,13-trimethyltricyclo[7.4.1.0⁵,¹⁴]tetradeca-3,5,7,9(14)-tetraene-2,10-dione

13-hydroxy-3-isopropyl-1,8,13-trimethyltricyclo[7.4.1.0⁵,¹⁴]tetradeca-3,5,7,9(14)-tetraene-2,10-dione

C20H24O3 (312.1725354)


   

15-ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.0⁴,¹².0⁵,¹⁰.0¹⁶,¹⁸]icosa-4(12),5,7,9-tetraen-2-ol

15-ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.0⁴,¹².0⁵,¹⁰.0¹⁶,¹⁸]icosa-4(12),5,7,9-tetraen-2-ol

C19H24N2O2 (312.18376839999996)


   

6-[(4-methoxyphenyl)methyl]-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-6-ium

6-[(4-methoxyphenyl)methyl]-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-6-ium

[C19H22NO3]+ (312.1599602)


   

(9s)-3,4-dihydroxy-16-methoxy-10,10-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,13,15-hexaen-10-ium

(9s)-3,4-dihydroxy-16-methoxy-10,10-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,13,15-hexaen-10-ium

[C19H22NO3]+ (312.1599602)